<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Endocrinol (Lausanne)</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Endocrinol (Lausanne)</journal-id>
<journal-id journal-id-type="publisher-id">Front. Endocrinol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Endocrinology</journal-title>
</journal-title-group>
<issn pub-type="epub">1664-2392</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31920975</article-id>
<article-id pub-id-type="pmc">6923197</article-id>
<article-id pub-id-type="doi">10.3389/fendo.2019.00864</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Endocrinology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Genotype-Phenotype Relationships and Endocrine Findings in Prader-Willi Syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Costa</surname>
<given-names>Régis Afonso</given-names>
</name>
<xref ref-type="author-notes" rid="fn002">
<sup>†</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/820112/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ferreira</surname>
<given-names>Igor Ribeiro</given-names>
</name>
<xref ref-type="author-notes" rid="fn002">
<sup>†</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/849580/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cintra</surname>
<given-names>Hiago Azevedo</given-names>
</name>
<uri xlink:href="http://loop.frontiersin.org/people/857444/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gomes</surname>
<given-names>Leonardo Henrique Ferreira</given-names>
</name>
<uri xlink:href="http://loop.frontiersin.org/people/849456/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Guida</surname>
<given-names>Letícia da Cunha</given-names>
</name>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/819266/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff><institution>Laboratório de Alta Complexidade, Instituto Nacional da Saúde da Mulher, da Criança e Do Adolescente Fernandes Figueira</institution>, <addr-line>Fiocruz</addr-line>, <addr-line>Rio de Janeiro</addr-line>, <country>Brazil</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Ana Rosa Pérez, National Council for Scientific and Technical Research, Argentina</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Christian P. Schaaf, Heidelberg University, Germany; Dag H. Yasui, University of California, Davis, United States</p>
</fn>
<corresp id="c001">*Correspondence: Letícia da Cunha Guida <email>leticia.guida@iff.fiocruz.br</email></corresp>
<fn fn-type="other" id="fn001">
<p>This article was submitted to Neuroendocrine Science, a section of the journal Frontiers in Endocrinology</p>
</fn>
<fn fn-type="other" id="fn002">
<p>†These authors have contributed equally to this work</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>13</day>
<month>12</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>10</volume>
<elocation-id>864</elocation-id>
<history>
<date date-type="received">
<day>30</day>
<month>9</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>26</day>
<month>11</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2019 Costa, Ferreira, Cintra, Gomes and Guida.</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder>Costa, Ferreira, Cintra, Gomes and Guida</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Prader-Willi syndrome (PWS) is a complex imprinting disorder related to genomic errors that inactivate paternally-inherited genes on chromosome 15q11-q13 with severe implications on endocrine, cognitive and neurologic systems, metabolism, and behavior. The absence of expression of one or more genes at the PWS critical region contributes to different phenotypes. There are three molecular mechanisms of occurrence: paternal deletion of the 15q11-q13 region; maternal uniparental disomy 15; or imprinting defects. Although there is a clinical diagnostic consensus criteria, DNA methylation status must be confirmed through genetic testing. The endocrine system can be the most affected in PWS, and growth hormone replacement therapy provides improvement in growth, body composition, and behavioral and physical attributes. A key feature of the syndrome is the hypothalamic dysfunction that may be the basis of several endocrine symptoms. Clinical and molecular complexity in PWS enhances the importance of genetic diagnosis in therapeutic definition and genetic counseling. So far, no single gene mutation has been described to contribute to this genetic disorder or related to any exclusive symptoms. Here we proposed to review individually disrupted genes within the PWS critical region and their reported clinical phenotypes related to the syndrome. While genes such as <italic>MKRN3, MAGEL2, NDN</italic>, or <italic>SNORD115</italic> do not address the full spectrum of PWS symptoms and are less likely to have causal implications in PWS major clinical signs, <italic>SNORD116</italic> has emerged as a critical, and possibly, a determinant candidate in PWS, in the recent years. Besides that, the understanding of the biology of the PWS SNORD genes is fairly low at the present. These non-coding RNAs exhibit all the hallmarks of RNA methylation guides and can be incorporated into ribonucleoprotein complexes with possible hypothalamic and endocrine functions. Also, DNA conservation between SNORD sequences across placental mammals strongly suggests that they have a functional role as RNA entities on an evolutionary basis. The broad clinical spectrum observed in PWS and the absence of a clear genotype-phenotype specific correlation imply that the numerous genes involved in the syndrome have an additive deleterious effect on different phenotypes when deficiently expressed.</p>
</abstract>
<kwd-group>
<kwd>Prader-Willi syndrome</kwd>
<kwd>genotype</kwd>
<kwd>phenotype</kwd>
<kwd>endocrine</kwd>
<kwd>imprinting</kwd>
<kwd>SNORDs</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">Fundação Oswaldo Cruz<named-content content-type="fundref-id">10.13039/501100006507</named-content></funding-source>
</award-group>
</funding-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="1"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="151"></ref-count>
<page-count count="11"></page-count>
<word-count count="9258"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Prader-Willi syndrome (PWS; OMIM 176270) was first described in 1956 by Andrea Prader, Alexis Labhart and Heinrich Willi based on a study of nine children with a common clinical tetrad: short stature, intellectual disability, obesity, and small hands and feet (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>). The phenotypic analysis was expanded in the following years and decades, revealing the complexity of the syndrome, affecting endocrine, cognitive and neurologic systems, metabolism, and behavior. PWS was the first human disease to be related to genomic imprinting errors, and also the first one shown to be caused by uniparental disomy (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4</xref>). This rare genetic disorder has a prevalence of 1 in 10,000–30,000 live births, males and females are affected equally in all ethnic groups (<xref ref-type="bibr" rid="B5">5</xref>).</p>
<p>The PWS critical region on chromosome 15q11-q13 is monoallelically expressed by paternally inherited genes, exclusively. The absence of expression of one or more of these genes contributes to different phenotypes of PWS (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>) and there are three main mechanisms of occurrence: paternal deletion of the 15q11-q13 region; maternal uniparental disomy 15; or imprinting defects (<xref ref-type="bibr" rid="B8">8</xref>–<xref ref-type="bibr" rid="B10">10</xref>). On the other hand, in the same region, the loss of expression of the <italic>UBE3A</italic> gene (preferentially maternally expressed) drives to Angelman syndrome, with completely different clinical characteristics. By their common implicated region and mechanisms, both syndromes are considered sister imprinted disorders (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B12">12</xref>).</p>
<p>Clinical manifestations vary with age, impacting multiple body systems (<xref ref-type="table" rid="T1">Table 1</xref>). Fetal size is usually within the normal range. Compared to unaffected siblings, birth weight and body mass index (BMI) are 15% lower on average. Prenatal hypotonia may cause decreased fetal movement, abnormal fetal position at delivery, and increased incidence of assisted delivery or cesarean section (<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B15">15</xref>).</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>Clinical characteristics and the nutritional phases in PWS.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Median ages</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Clinical characteristics</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Prenatal—birth</td>
<td align="left" colspan="1" rowspan="1" valign="top">Decreased fetal movements</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Lower birth weight and body mass compared to sibs</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">0–9 months</td>
<td align="left" colspan="1" rowspan="1" valign="top">Severe hypotonia</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Feeding problems and failure to thrive</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">9–25 months</td>
<td align="left" colspan="1" rowspan="1" valign="top">Improved feeding and appetite</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Normal growth</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Delayed physical and social milestones</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">2.1–4.5 years</td>
<td align="left" colspan="1" rowspan="1" valign="top">Weight increasing without appetite increase or excess calories</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">4.5–8 years</td>
<td align="left" colspan="1" rowspan="1" valign="top">Weight increasing with appetite increase</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Global developmental delay</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">8 years—adulthood</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hyperphagic, rarely feels satiety</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Mild intellectual disability and behavior problems</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Hypogonadism</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Adulthood</td>
<td align="left" colspan="1" rowspan="1" valign="top">Appetite no longer insatiable for some</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Short stature and small hands and feet</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>Gunay-Aygun et al. (<xref ref-type="bibr" rid="B13">13</xref>); Miller et al. (<xref ref-type="bibr" rid="B14">14</xref>); Driscoll et al. (<xref ref-type="bibr" rid="B5">5</xref>)</italic>.</p>
</table-wrap-foot>
</table-wrap>
<p>Severe hypotonia is a clinical hallmark of PWS, leading to failure to thrive during infancy due to lethargy and poor suck. Other common neonatal findings are decreased movement and spontaneous arousal, weak cry, thick saliva, and poor reflexes (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B16">16</xref>). Around 9 months of life, eating behavior starts to normalize, and the hypotonic status tends to improve, but mild-to-moderate hypotonia persists throughout life, with reduced muscle mass and tone (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B17">17</xref>).</p>
<p>Physical and social milestones (as sitting, walking, first words, and reading) are delayed and can be achieved at about double the normal age (<xref ref-type="bibr" rid="B18">18</xref>). Most individuals have mild intellectual disability, learning difficulties, and poor academic performance. During early infancy, characteristic behavioral problems are common, such as stubbornness, manipulation, compulsiveness, self-injury, and difficulty with change in routine (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B20">20</xref>). Another common feature in the syndrome is sleep disruption, related to sleep apnea that impairs the quality and efficiency of sleep, frequently associated with excessive daytime sleepiness, and sedentary behavior with a higher predisposition to obesity (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B21">21</xref>).</p>
<p>In later childhood, individuals with PWS will reach severe obesity unless food intake is strictly controlled by family and caretakers. The lack of satiety (hypothalamic origin) results in hyperphagia, with obsessive food seeking. In uncontrolled cases, obesity, and its complications are the major causes of morbidity and mortality: respiratory insufficiency, cardiovascular problems, metabolic syndrome, sleep apnea, and type 2 diabetes mellitus (<xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B23">23</xref>). Mortality rates range between 1.25 and 3% per year (<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B25">25</xref>). Hyperphagia in PWS is still not fully understood and controlling appetite remains a challenge.</p>
<p>The endocrine system can be the most affected in PWS. Growth hormone (GH) deficiency is present in up to 74% of cases and is associated with short stature, small hands and feet, low motor strength, increased fat mass, and decreased movement and energy expenditure (<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B27">27</xref>). GH replacement therapy has shown positive effects not only on growth and body composition but also on development, behavior, and nocturnal respiratory abnormalities, although a careful respiratory follow up is mandatory during long-term GH administration (<xref ref-type="bibr" rid="B28">28</xref>–<xref ref-type="bibr" rid="B34">34</xref>). Hypogonadism affects both sexes and is manifested as hypogenitalism, incomplete pubertal development and infertility in most individuals (<xref ref-type="bibr" rid="B35">35</xref>). Hypogonadism is thought to have a hypothalamic origin, and subsequent insufficient secretion of pituitary gonadotropins and sexual hormones (testosterone or estrogen) (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B36">36</xref>, <xref ref-type="bibr" rid="B37">37</xref>). Other endocrine abnormalities include hypothyroidism (20–30%), central adrenal insufficiency (about 5%) and type 2 diabetes (up to 25%) due to obesity complications (<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B38">38</xref>–<xref ref-type="bibr" rid="B41">41</xref>).</p>
</sec>
<sec id="s2">
<title>Molecular Genetics and Diagnostic</title>
<p>The hypothalamic dysfunction observed in PWS may be the basis of several symptoms (such as hypotonia, developmental delay or obesity) that overlaps features of other conditions on clinical grounds, like normal obesity and intellectual disability (<xref ref-type="bibr" rid="B42">42</xref>). Definitive diagnosis requires DNA testing. The PWS region spans ~6 Mb on the long arm of chromosome 15 (<xref ref-type="fig" rid="F1">Figure 1</xref>). Within this region, at least 2.5 Mb comprises genes with differential expression depending on parental origin. This locus holds protein-coding genes and several non-coding RNAs, which are believed to be involved in the regulation of alternative splicing, mainly in the brain (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B16">16</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p>Chromosome map of 15q11.2-q13.1 region. Symbols: ovals, protein-coding genes; rectangles, RNA genes; BP1, breakpoint 1; BP2, breakpoint 2; BP3, breakpoint 3; Type 1, BP1-BP3 deletion with ~6 Mb; Type 2, BP2-BP3 deletion with ~5.3 Mb; Cen, Centromere; Tel, Telomere; IC, Imprinting Center.</p>
</caption>
<graphic xlink:href="fendo-10-00864-g0001"></graphic>
</fig>
<p>The bicistronic gene <italic>SNURF-SNRPN</italic> is central to the PWS region and crucial to understanding the methylation pattern in the syndrome. The CpG island at the 5′ end of <italic>SNURF-SNRPN</italic> (encompassing the promoter region, exon 1 and intron 1) is differentially imprinted according to parental origin: the unmethylated paternal allele is expressed while the methylated maternal allele is repressed (<xref ref-type="bibr" rid="B43">43</xref>). The PWS imprinting center (PWS-IC, <xref ref-type="fig" rid="F1">Figure 1</xref>) involves the CpG island and exon 1 within the 4.3 Kb smallest region of overlap (<xref ref-type="bibr" rid="B44">44</xref>). Furthermore, <italic>SNURF-SNRPN</italic> expression produces a long transcript also including PWS-IC, Six snoRNA genes, <italic>IPW</italic> and <italic>UBE3A</italic> antisense (<xref ref-type="fig" rid="F1">Figure 1</xref>), which is hypothesized to repress paternal <italic>UBE3A</italic> (<xref ref-type="bibr" rid="B45">45</xref>–<xref ref-type="bibr" rid="B48">48</xref>).</p>
<p>Most PWS patients (65–75%) present a 5–6 Mb deletion at 15q11-q13 from the paternal origin (<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B49">49</xref>). There are two proximal breakpoints and a common distal breakpoint (<xref ref-type="fig" rid="F1">Figure 1</xref>), these regions are flanked by low copy repeat sequences that predispose to abnormal chromosomal pairing and uneven crossing-over, resulting in errors during meiosis (<xref ref-type="bibr" rid="B50">50</xref>, <xref ref-type="bibr" rid="B51">51</xref>). Maternal Uniparental Disomy (mDUP) occurs when both chromosomes 15 are inherited from the mother and accounts for ~20–30% of cases, being associated with advanced maternal age (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B15">15</xref>). Imprinting defects are caused by epimutations or microdeletions in the PWS-IC in 1–3% of PWS cases. These individuals have biparental allele inheritance, but a maternal-only DNA methylation pattern (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B52">52</xref>).</p>
<p>Clinical and molecular complexity in PWS enhances the importance of genetic diagnosis in therapeutic definition and genetic counseling. Only DNA methylation analysis can consistently diagnose the syndrome in all three molecular classes (deletion, mUPD, and imprinting defects) and differentiate it from Angelman Syndrome (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B52">52</xref>). The methylation analysis targets the 5′ CpG island of the <italic>SNURF-SNRPN</italic> locus and will correctly diagnose more than 99% of cases. Currently, there are three assays with this detection capacity: methylation-specific PCR (MS-PCR, the gold standard), methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) and methylation-sensitive high-resolution melting (MS-HRM) (<xref ref-type="bibr" rid="B53">53</xref>–<xref ref-type="bibr" rid="B58">58</xref>).</p>
<p>After methylation status confirmation, defining the exact molecular mechanism behind the syndrome origin is important for genetic counseling. Sporadic deletion cases have &lt;1% risk of recurrence, while rare cases of structural abnormalities involving chromosome 15 (such as translocations, ring formation, isochromosome or inversions) can be as high as 25–50% and fluorescence <italic>in situ</italic> hybridization (FISH) can address the deletion source (<xref ref-type="bibr" rid="B59">59</xref>–<xref ref-type="bibr" rid="B65">65</xref>). mUPD 15 is typically <italic>de novo</italic> (recurrence &lt;1%), proband and parents should be investigated by small nucleotide polymorphisms (SNP) microarray for accurate counseling (<xref ref-type="bibr" rid="B66">66</xref>, <xref ref-type="bibr" rid="B67">67</xref>). Most imprinting defects cases are classified as epimutations with no alteration in the DNA sequence and have &lt;1% recurrence risk. However, 15% of individuals with imprinting defects present a paternally inherited microdeletion (7.5–100 kb) in the PWS-IC, in which cases the risk of recurrence is 50%. IC analysis by MS-MLPA or DNA sequencing will address the exact origin of this event (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B44">44</xref>).</p>
</sec>
<sec id="s3">
<title>Genotype-Phenotype Relationships in Prader-Willi Syndrome</title>
<p>None of the PWS genetic errors are associated with exclusive symptoms. However, the most prevalent molecular classes (deletion and mUPD) show statistical differences in frequency or severity in some clinical characteristics. Patients with paternal deletion were more related to feeding problems, sleep disturbances, hypopigmentation and speech and language deficits (<xref ref-type="bibr" rid="B68">68</xref>). Individuals with the larger type 1 deletion (<xref ref-type="fig" rid="F1">Figure 1</xref>) have been reported to have better academic performance and intellectual abilities, and more compulsiveness when compared to type 2 deletion patients (<xref ref-type="bibr" rid="B69">69</xref>, <xref ref-type="bibr" rid="B70">70</xref>). Several other features are more common in mUPD individuals, such as post-term delivery, higher verbal IQ, psychosis and autism spectrum disorder (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B69">69</xref>, <xref ref-type="bibr" rid="B71">71</xref>–<xref ref-type="bibr" rid="B75">75</xref>). On the other hand, mUPD patients are less likely to have the typical PWS facial appearance or hypopigmentation (<xref ref-type="bibr" rid="B16">16</xref>). So far, no single gene mutation has been described to contribute to this genetic disorder. Here we proposed to review genes individually disrupted within the PWS critical region and their reported clinical phenotypes related to the syndrome.</p>
<p>The Makorin Ring Finger Protein 3 (<italic>MKRN3, ZNF127</italic>) gene encodes a zinc finger protein of the Makorin family and is paternally expressed ubiquitously in human adult tissues, with the highest level in testis, although its exact mechanism of action remains to be elucidated (<xref ref-type="bibr" rid="B76">76</xref>). This gene is associated with inhibition of puberty initiation, and loss of function mutations in <italic>MKRN3</italic> are recognized as the main genetic cause of Central Precocious Puberty (<xref ref-type="bibr" rid="B77">77</xref>). This correlation has been described by distinct studies with different ethnic groups, affecting equally both sexes, with all mutations segregated in a paternal manner at <italic>MKRN3</italic> (<xref ref-type="bibr" rid="B78">78</xref>–<xref ref-type="bibr" rid="B81">81</xref>). Experimental models with mice also support the correlation between mutations in <italic>Mkrn3</italic> and puberty dysfunctions, suggesting it may play a role in the hypothalamic-pituitary-gonadal axis (<xref ref-type="bibr" rid="B77">77</xref>–<xref ref-type="bibr" rid="B79">79</xref>). Altogether, this makes <italic>MKRN3</italic> a strong candidate gene for hypogonadism and infertility in PWS.</p>
<p>The physiological consequence of loss of expression of MAGE Family Member L2 (<italic>MAGEL2</italic>) has been related to phenotypic characteristics of PWS (<xref ref-type="bibr" rid="B82">82</xref>). <italic>Magel2</italic>-null mice exhibited endocrine dysfunction similar to PWS: neonatal growth retardation; excessive weight gain; increased adiposity after weaning; impaired hypothalamic regulation and changes in circadian rhythm (<xref ref-type="bibr" rid="B83">83</xref>, <xref ref-type="bibr" rid="B84">84</xref>). Hyperphagia, commonly observed in individuals with PWS, is associated with a defect in the hypothalamic arcuate nucleus, which is the major action site of multiple complex interactions between neuropeptide Y (NPY), agouti-related peptide (AgRP), proopiomelanocortin (POMC), and leptin, regulating the food intake and body weight (<xref ref-type="bibr" rid="B85">85</xref>, <xref ref-type="bibr" rid="B86">86</xref>). NPY/AgRP interaction stimulates food intake, whereas POMC reduces it. Loss of <italic>MAGEL2</italic> expression disturbs leptin-mediated depolarization of POMC neurons, indicating that food intake is being less repressed and fat storage regulated by leptin is uncontrolled (<xref ref-type="bibr" rid="B87">87</xref>, <xref ref-type="bibr" rid="B88">88</xref>). Additionally, loss of expression of <italic>Magel2</italic> impairs reproductive function in mice. <italic>Magel2</italic>-null females showed extended and irregular estrous cycles, while males displayed decreased testosterone levels, and reduced pheromone detection, which has a direct relationship between the main olfactory epithelium and the hypothalamic GnRH neuronal system (<xref ref-type="bibr" rid="B89">89</xref>, <xref ref-type="bibr" rid="B90">90</xref>). These results suggest that lack of expression of <italic>MAGEL2</italic> contributes to the reproductive deficiencies observed in PWS and also highlights the role of normal circadian rhythm in maintaining fertility.</p>
<p>Therein, specific point mutations on the paternal allele of <italic>MAGEL2</italic> were reported in 4 individuals with PWS spectrum phenotype: muscle hypotonia, weight gain, developmental delay, and hypogonadism. Although all clinical characteristics were consistent with PWS clinical diagnosis, methylation analysis on the promoter-exon 1 region of the <italic>SNURF-SNRPN</italic> gene showed normal allelic patterns (<xref ref-type="bibr" rid="B82">82</xref>). All four subjects were diagnosed with an autism spectrum disorder, intellectual disability, and different degrees of clinical and behavioral features of PWS. Although not a main characteristic, autism is present in 19% of individuals with PWS (<xref ref-type="bibr" rid="B71">71</xref>). These four individuals presented a normal methylation pattern, not compatible with PWS, despite similar clinical conditions, which was subsequently called Schaaf-Yang Syndrome (SYS) (<xref ref-type="bibr" rid="B91">91</xref>). Recent data of an international cohort of 78 patients with truncating <italic>MAGEL2</italic> mutations emphasized that SYS overlaps with PWS on clinical grounds in the early stages of life but diverges with the advance of childhood and adolescence (<xref ref-type="bibr" rid="B92">92</xref>). PWS features such as hypopigmentation, facial appearance, small hands and feet, thick saliva, behavioral problems are not commonly seen in SYS. And above all distinct symptoms, SYS does not usually cause the high appetite and severe obesity observed in PWS, which can disassociate <italic>MAGEL2</italic> and the hyperphagia condition.</p>
<p>The Necdin (<italic>NDN</italic>) gene encodes a DNA binding protein highly expressed in mature hypothalamic neurons (<xref ref-type="bibr" rid="B93">93</xref>). It has been postulated as a key regulator of GnRH levels both <italic>in vitro</italic> and <italic>in vivo</italic>, modulating essential intracellular processes for neurite and axonal outgrowth (<xref ref-type="bibr" rid="B94">94</xref>–<xref ref-type="bibr" rid="B96">96</xref>). Lack of <italic>NDN</italic> reduces GnRH gene expression, leads to decreased numbers of GnRH neurons, and decreased targeting of GnRH axons to the median eminence of the hypothalamus during development, which can contribute to hypogonadism and infertility in PWS. Also, Necdin paternal-deficient mice were associated with alterations in serotonin and respiratory systems, resulting in irregular breathing and sleep apneas, commonly observed in PWS. Another important evidence reported with <italic>Ndn</italic>-KO mice was sudden death due to respiratory disorders, which is the main side effect associated with GH therapy (<xref ref-type="bibr" rid="B97">97</xref>–<xref ref-type="bibr" rid="B99">99</xref>). <italic>NDN</italic> might be a genetic factor contributing to apneas and respiratory dysfunctions of PWS.</p>
<p>Interestingly, (<xref ref-type="bibr" rid="B100">100</xref>) described three patients with atypical deletions related to PWS. Patient 1 was deleted for <italic>MKRN3, MAGEL2</italic>, and <italic>NDN</italic> with no PWS major clinical criteria, except for obesity, developmental delay, and high pain threshold. Patients 2 and 3 had a deletion encompassing <italic>NPAP1, SNURF-SNRPN</italic>, and the SNORD genes, but did not reach <italic>MKRN3, MAGEL2</italic>, and <italic>NDN</italic>, and presented PWS major clinical signs (<xref ref-type="bibr" rid="B100">100</xref>). This report suggests that a paternal deficiency of <italic>MKRN3, MAGEL2</italic>, and <italic>NDN</italic> is not sufficient to generate the full PWS phenotype and postulates <italic>NPAP1, SNURF-SNRPN</italic>, and the SNORD genes (discussed ahead) to be the critical region for PWS. These results contradict other studies and exemplify the complexity to establish a genotype-phenotype relationship in PWS (<xref ref-type="bibr" rid="B78">78</xref>, <xref ref-type="bibr" rid="B82">82</xref>, <xref ref-type="bibr" rid="B83">83</xref>, <xref ref-type="bibr" rid="B98">98</xref>, <xref ref-type="bibr" rid="B99">99</xref>, <xref ref-type="bibr" rid="B101">101</xref>, <xref ref-type="bibr" rid="B102">102</xref>).</p>
<p>The Prader-Willi region encompasses a series of long non-coding RNAs (lncRNAs) which are characteristically more than 200 nucleotides long and can be involved in epigenetic modifications of DNA, and regulation of gene expression at transcriptional and post-transcriptional levels (<xref ref-type="bibr" rid="B103">103</xref>–<xref ref-type="bibr" rid="B105">105</xref>). The first lncRNA inside the PWS region is the Prader-Willi Region Non-Protein Coding RNA 1 (<italic>PWRN1</italic>), biallelically expressed in the testis and kidneys, and monoallelic expressed in the brain, in addition to being an alternative 5′ part of SNURF–SNRPN (<xref ref-type="bibr" rid="B106">106</xref>). Wawrzik et al. (<xref ref-type="bibr" rid="B107">107</xref>) hypothesized that the action of <italic>PWRN1</italic> on the imprinting mechanism may be indirect through keeping the paternal allele in an open chromatin configuration, allowing access to transcription factors (<xref ref-type="bibr" rid="B107">107</xref>). The main limitation for further confirmation studies is the lack of gene orthology in mice (<xref ref-type="bibr" rid="B108">108</xref>–<xref ref-type="bibr" rid="B110">110</xref>).</p>
<p>The Nuclear Pore Associated Protein 1 (<italic>NPAP1</italic>), formerly known as Chromosome 15 Open Reading Frame 2 (C15orf2), is an intronless gene that is biallelically expressed in adult testis and monoallelically expressed in fetal brain, including the hypothalamus which is related to several endocrine features of PWS (<xref ref-type="bibr" rid="B106">106</xref>, <xref ref-type="bibr" rid="B111">111</xref>). Moreover, this gene is associated with the Nuclear Pore Complex (NPC), in which the main function is to regulate macromolecular transport between the nucleus and the cytoplasm. NPCs also participates in several nuclear processes, such as gene regulation, mRNA biogenesis, and cell cycle control. Likewise <italic>PWRN1</italic>, due to the lack of orthology in mice the exact role of the <italic>NPAP1</italic> gene in the development of PWS is not clear (<xref ref-type="bibr" rid="B112">112</xref>).</p>
<p>The Small Nuclear Ribonucleoprotein Polypeptide N (<italic>SNRPN</italic>) gene is located within the central region associated with PWS and has an important regulatory role over the imprinted genes located in chromosome 15 (<xref ref-type="bibr" rid="B113">113</xref>, <xref ref-type="bibr" rid="B114">114</xref>), while the SNRPN Upstream Reading Frame (<italic>SNURF</italic>) gene is encoded by an evolutionarily-conserved upstream open reading frame and is localized to the nucleus (<xref ref-type="bibr" rid="B115">115</xref>). <italic>SNURF-SNRPN</italic> is a complex bicistronic gene encoding two different proteins, and the PWS-IC is found at its 5' end. <italic>SNURF</italic> is encoded by exons 1–3 and produces a small nuclear protein of unknown function (<xref ref-type="bibr" rid="B113">113</xref>), exons 4–10 correspond to the <italic>SNRPN</italic> portion and encode the protein SmN, involved in mRNA splicing (<xref ref-type="bibr" rid="B43">43</xref>). It also holds six snoRNA genes located telomerically which are expressed as a long transcript (<xref ref-type="bibr" rid="B46">46</xref>). The SmN protein shows the highest expression in the brain and heart (<xref ref-type="bibr" rid="B115">115</xref>–<xref ref-type="bibr" rid="B117">117</xref>). Despite its central position in PWS, the function and regulation of the many alternative transcripts of <italic>SNURF-SNRPN</italic> are still poorly understood (<xref ref-type="bibr" rid="B48">48</xref>).</p>
<p>Within the long <italic>SNURF-SNRPN</italic> transcript, there are a series of Small Nucleolar RNAs (snoRNAs) thought to participate in DNA methylation, alternative splicing and post-transcriptional regulation (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B118">118</xref>). The PWS region encompasses five single copy snoRNA genes (<italic>SNORD64, SNORD107, SNORD108, SNORD109A</italic>, and <italic>SNORD109B</italic>) and two snoRNA gene clusters (<italic>SNORD115</italic> and <italic>SNORD116</italic>). The expression of SNORD genes varies in different human and mouse tissues, suggesting specificity in post-transcriptional activity (<xref ref-type="bibr" rid="B46">46</xref>, <xref ref-type="bibr" rid="B119">119</xref>–<xref ref-type="bibr" rid="B122">122</xref>). Although most of the SNORDs are ubiquitously expressed in human tissues, <italic>SNORD115</italic> and <italic>SNORD109B</italic> appear to be restricted to the brain. Our understanding of the single-copy SNORDs in PWS remains extremely limited, but some progress has been made with the clusters: <italic>SNORD116</italic> has 29 tandemly repeats and <italic>SNORD115</italic> is composed of 48 gene copies (<xref ref-type="bibr" rid="B118">118</xref>). Given that SNORD sequences are well-conserved across placental mammals (especially in primates and rodents), this suggests they have an evolutionary functional role (<xref ref-type="bibr" rid="B123">123</xref>, <xref ref-type="bibr" rid="B124">124</xref>).</p>
<p>A minimal critical region has emerged implicating that the <italic>SNORD116</italic> cluster is crucial for most of the PWS phenotype, based on clinical evidence on rare patients with small deletions (150–200 Kb) or translocations (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B125">125</xref>–<xref ref-type="bibr" rid="B128">128</xref>). Experimental studies on <italic>Snord116</italic>-KO mice displayed PWS features such as post-natal growth retardation and hyperphagia (<xref ref-type="bibr" rid="B129">129</xref>–<xref ref-type="bibr" rid="B132">132</xref>). Remarkably, a <italic>Snord116</italic>-KO mice model specifically in NPY neurons in the hypothalamic arcuate nucleus summarized the same overall phenotype observed in mice lacking <italic>Snord116</italic> globally; low birth weight, increased body weight gain in early adulthood, increased energy expenditure and hyperphagia (<xref ref-type="bibr" rid="B130">130</xref>). This suggests an important role of <italic>Snord116</italic> in controlling NPY neuronal functions, and thus food intake and energy homeostasis. Also, a recent study reported <italic>Snord116</italic>-deficient mice with decreased activity of the hypothalamic prohormone convertase PC1 impairing the prohormone processing of proinsulin, pro-GH-releasing hormone, and proghrelin, pointing to an important part of <italic>SNORD116</italic> and PC1 deficiency in the main neuroendocrine features of PWS (<xref ref-type="bibr" rid="B133">133</xref>). Interestingly, it was shown that a mouse <italic>Snord116</italic> deletion model displayed loss or shift in methylation dynamics in 97% of CpG islands in the cerebral cortex dependent on the circadian cycle. And this disrupted epigenetic rhythm had a strong overlap between mouse and human genes related to meal timing, circadian biology, and obesity (<xref ref-type="bibr" rid="B134">134</xref>). In the recent years, <italic>SNORD116</italic> has emerged as a critical, and possibly, determinant candidate in PWS not only by its highly conserved sequence in the minimal critical region, but also because paternal deletions affecting the expression of <italic>NDN, MKRN3, MAGEL2</italic>, or <italic>SNORD115</italic> genes do not address the full spectrum of PWS symptoms (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B100">100</xref>, <xref ref-type="bibr" rid="B123">123</xref>, <xref ref-type="bibr" rid="B135">135</xref>, <xref ref-type="bibr" rid="B136">136</xref>).</p>
<p>The Imprinted in Prader-Willi Syndrome (<italic>IPW</italic>) gene is a lncRNA known to modulate another evolutionarily distinct imprinted gene cluster at the human chromosomal region 14q32 expressed only from maternally inherited alleles (<xref ref-type="bibr" rid="B137">137</xref>). <italic>IPW</italic> is widely expressed both in fetal and adult tissues, exclusively from the paternal allele (<xref ref-type="bibr" rid="B138">138</xref>). It has been postulated that <italic>IPW</italic> has no biological consequences in PWS, based on the relatively poor conservation between human and mouse sequences (<xref ref-type="bibr" rid="B138">138</xref>), and the fact that mice with a paternally inherited deletion including <italic>Ipw</italic> did not show PWS symptoms (<xref ref-type="bibr" rid="B139">139</xref>). However, Stelzer et al. (<xref ref-type="bibr" rid="B137">137</xref>) proposed that lack of expression of <italic>IPW</italic> results in aberrant upregulation of maternally expressed genes at the 14q32 imprinted cluster, pointing that the action of <italic>IPW</italic> on the imprinting mechanism of this locus occurs by histone modification, and consequently, transcription reduction (<xref ref-type="bibr" rid="B137">137</xref>). This hypothesis is supported by clinical reports of affected individuals with mUPD 14 (overexpression of maternal genes) presenting PWS-like phenotypes, such as neonatal hypotonia, small hands and feet, intellectual disability and hyperphagia (<xref ref-type="bibr" rid="B140">140</xref>–<xref ref-type="bibr" rid="B142">142</xref>). These findings pinpoint a regulatory cross-talk between 15q11-13 and 14q32 imprinted loci, but further, suggest that some PWS phenotypes may arise from different chromosomal regions other than the PWS critical locus (<xref ref-type="bibr" rid="B143">143</xref>, <xref ref-type="bibr" rid="B144">144</xref>).</p>
<p><italic>SNORD115</italic> gene is the most characterized SNORD within the PWS region. It presents a complementary sequence of 18 nucleotides with the mRNA encoding the serotonin receptor 5-HT2C, perfectly base pairing with exon V that undergoes both alternative RNA splicing and RNA editing (post-transcriptional changes to specific nucleotide sequences) (<xref ref-type="bibr" rid="B118">118</xref>). Mice with a large deletion encompassing the <italic>Snord115</italic> cluster developed normally to adulthood with apparently no significant defects (<xref ref-type="bibr" rid="B139">139</xref>). And there are also clinical reports on patients with an entire deletion of the <italic>SNORD115</italic> gene cluster that did not present any PWS major clinical signs (<xref ref-type="bibr" rid="B135">135</xref>, <xref ref-type="bibr" rid="B136">136</xref>). Taken together, these findings suggest that lack of <italic>SNORD115</italic> is not sufficient to cause PWS, but a phenotypic effect when absent along with other genes in the PWS critical region cannot be excluded. Actually, the <italic>5-HT2C</italic> gene encodes G protein-coupled receptor specific to the brain, whose activation is associated with a variety of physiological processes, such as dopamine modulation, anxiety, sleep regulation, satiety response, energy balance, and locomotor activity (<xref ref-type="bibr" rid="B145">145</xref>). Interestingly, experimental studies have described 5-HT2C receptor knockout mice that developed are hyperphagia and late-onset obesity, two major clinical features of PWS in humans (<xref ref-type="bibr" rid="B146">146</xref>, <xref ref-type="bibr" rid="B147">147</xref>). Therefore, the absence of <italic>SNORD115</italic> expression in PWS accompanied by the possible post-transcriptional impairment of the 5-HT2C receptor activity may be partly responsible for some of the behavioral and metabolic features of the syndrome.</p>
<p>The establishment of a causal genotype-phenotype relationship can bring light to new therapeutic approaches for PWS. Epigenetic therapy has been used in cancer treatment mostly focusing on the identification of small molecules and compounds with the capacity to reverse the epigenetic changes (epigenome reprogramming) (<xref ref-type="bibr" rid="B145">145</xref>, <xref ref-type="bibr" rid="B148">148</xref>). The successful experience obtained from the epigenetic-cancer therapies contributes to the development of similar approaches for genomic imprinting disorders. Recent studies have shown that histone methyltransferase inhibitors are capable of reactivating the expression of paternally expressed SNRPN and <italic>SNORD116</italic> from the maternal chromosome, both in PWS mouse models and in cultured PWS patient-derived fibroblasts (<xref ref-type="bibr" rid="B149">149</xref>, <xref ref-type="bibr" rid="B150">150</xref>). Although further investigation needs to be performed <italic>in vivo</italic>, epigenetic therapy aiming PWS genes in the maternal chromosome could reverse, or at least regulate, some PWS clinical conditions such as hyperphagia and behavioral problems (<xref ref-type="bibr" rid="B151">151</xref>). This data supports future studies to assess translational epigenetic-based therapies for PWS in humans.</p>
</sec>
<sec id="s4" sec-type="conclusions">
<title>Conclusion</title>
<p>PWS is a complex imprinting disorder caused by the lack of expression of paternally-inherited genes on chromosome 15q11-q13 with severe implications on endocrine, cognitive and neurologic systems, metabolism, and behavior. The PWS critical region encompasses five protein-coding genes (<italic>MKRN3, MAGEL2, NDN, NPAP1</italic>, and <italic>SNURF-SNRPN</italic>) and more than 80 RNA genes (<italic>PWRN1, IPW</italic>, and several SNORDs) but their contribution to unique PWS phenotypes is still unclear. The broad clinical spectrum and the absence of a clear genotype-phenotype specific correlation imply that the numerous genes involved in PWS have an additive deleterious effect when deficiently expressed. So far, the lack of expression of the <italic>SNORD116</italic> gene cluster has arisen as the best explanation for most of the PWS phenotype, yet there is a clear need to investigate more of its mechanism of action, especially the incorporation into ribonucleoprotein complexes, possibly acting in hypothalamic and endocrine functions in adulthood and perinatal period. Besides <italic>SNORD115</italic> and <italic>SNORD116</italic>, our understanding of the biology of the PWS SNORD genes is still rather shallow. These SNORDs exhibit all the hallmarks of RNA methylation guides and can associate with other proteins to form functional ribonucleoprotein complexes. Also, the SNORD sequences are well-conserved across placental mammals, strongly asserting that they have a functional role as RNA entities under evolutionary pressure. A better understanding about genotype-phenotype in PWS can open space for new therapeutic approaches especially for patients that present side effects related to the current standard treatment, and develop genetic counseling for the different levels of severity in PWS that require specific and constant medical follow-up, improving the life quality of patients, family, and caretakers.</p>
</sec>
<sec id="s5">
<title>Author Contributions</title>
<p>RC, IF, HC, and LGu contributed to the writing of the manuscript. LGo provided consultation and contributed to the writing of the manuscript.</p>
<sec>
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> This work was supported by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPQ) and was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (CAPES) - Finance Code 001.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prader</surname><given-names>A</given-names></name><name><surname>Labhart</surname><given-names>A</given-names></name><name><surname>Willi</surname><given-names>H</given-names></name></person-group>
<article-title>Ein syndrom von adipositas, kleinwuchs, kryptorchismus und oligophrenie nach myatonieartigem zustand im neugeborenenalter</article-title>. <source/>Schweiz Med Wochenschr. (<year>1956</year>) <volume>86</volume>:<fpage>1260</fpage>–<lpage>1</lpage>.</mixed-citation>
</ref>
<ref id="B2">
<label>2.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butler</surname><given-names>MG</given-names></name><name><surname>Meaney</surname><given-names>FJ</given-names></name><name><surname>Palmer</surname><given-names>CG</given-names></name><name><surname>Opitz</surname><given-names>JM</given-names></name><name><surname>Reynolds</surname><given-names>JF</given-names></name></person-group>. <article-title>Clinical and cytogenetic survey of 39 individuals with Prader-Labhart-Willi syndrome</article-title>. <source/>Am J Med Genet. (<year>1986</year>) <volume>23</volume>:<fpage>793</fpage>–<lpage>809</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.1320230307</pub-id><pub-id pub-id-type="pmid">3953677</pub-id></mixed-citation>
</ref>
<ref id="B3">
<label>3.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicholls</surname><given-names>RD</given-names></name><name><surname>Knoll</surname><given-names>JH</given-names></name><name><surname>Butler</surname><given-names>MG</given-names></name><name><surname>Karam</surname><given-names>S</given-names></name><name><surname>Lalande</surname><given-names>M</given-names></name></person-group>. <article-title>Genetic imprinting suggested by maternal heterodisomy in nondeletion Prader-Willi syndrome</article-title>. <source/>Nature. (<year>1989</year>) <volume>342</volume>:<fpage>281</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1038/342281a0</pub-id><pub-id pub-id-type="pmid">2812027</pub-id></mixed-citation>
</ref>
<ref id="B4">
<label>4.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butler</surname><given-names>MG</given-names></name></person-group>. <article-title>Genomic imprinting disorders in humans: a mini-review</article-title>. <source/>J Assist Reprod Genet. (<year>2009</year>) <volume>26</volume>:<fpage>477</fpage>–<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1007/s10815-009-9353-3</pub-id><pub-id pub-id-type="pmid">19844787</pub-id></mixed-citation>
</ref>
<ref id="B5">
<label>5.</label>
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Driscoll</surname><given-names>DJ</given-names></name><name><surname>Miller</surname><given-names>JL</given-names></name><name><surname>Schwartz</surname><given-names>S</given-names></name><name><surname>Cassidy</surname><given-names>SB</given-names></name></person-group>
<article-title>Prader-Willi Syndrome</article-title>. In: <person-group person-group-type="editor"><name><surname>Adam</surname><given-names>MP</given-names></name><name><surname>Ardinger</surname><given-names>HH</given-names></name><name><surname>Pagon</surname><given-names>RA</given-names></name><name><surname>Wallace</surname><given-names>SE</given-names></name><name><surname>Bean</surname><given-names>LJH</given-names></name><name><surname>Stephens</surname><given-names>K</given-names></name><etal></etal></person-group>, editors. <source/>GeneReviews. <publisher-loc>Seattle, WA</publisher-loc>: <publisher-name>University of Washington</publisher-name> (<year>2017</year>). p. <fpage>1</fpage>–<lpage>38</lpage>.</mixed-citation>
</ref>
<ref id="B6">
<label>6.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whittington</surname><given-names>JE</given-names></name><name><surname>Butler</surname><given-names>JV</given-names></name><name><surname>Holland</surname><given-names>AJ</given-names></name></person-group>. <article-title>Changing rates of genetic subtypes of Prader-Willi syndrome in the UK</article-title>. <source/>Eur J Hum Genet. (<year>2007</year>) <volume>15</volume>:<fpage>127</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1038/sj.ejhg.5201716</pub-id><pub-id pub-id-type="pmid">16957680</pub-id></mixed-citation>
</ref>
<ref id="B7">
<label>7.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cassidy</surname><given-names>SB</given-names></name><name><surname>Driscoll</surname><given-names>DJ</given-names></name></person-group>. <article-title>Prader–Willi syndrome</article-title>. <source/>Eur J Hum Genet. (<year>2009</year>) <volume>17</volume>:<fpage>3</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1038/ejhg.2008.165</pub-id><pub-id pub-id-type="pmid">18781185</pub-id></mixed-citation>
</ref>
<ref id="B8">
<label>8.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicholls</surname><given-names>RD</given-names></name><name><surname>Knepper</surname><given-names>JL</given-names></name></person-group>. <article-title>Genome organization, function, and imprinting in Prader-Willi and Angelman syndromes</article-title>. <source/>Annu Rev Genomics Hum Genet. (<year>2001</year>) <volume>2</volume>:<fpage>153</fpage>–<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.genom.2.1.153</pub-id><pub-id pub-id-type="pmid">11701647</pub-id></mixed-citation>
</ref>
<ref id="B9">
<label>9.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angulo</surname><given-names>MA</given-names></name><name><surname>Butler</surname><given-names>MG</given-names></name><name><surname>Cataletto</surname><given-names>ME</given-names></name></person-group>. <article-title>Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings</article-title>. <source/>J Endocrinol Invest. (<year>2015</year>) <volume>38</volume>:<fpage>1249</fpage>–<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1007/s40618-015-0312-9</pub-id><pub-id pub-id-type="pmid">26062517</pub-id></mixed-citation>
</ref>
<ref id="B10">
<label>10.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheon</surname><given-names>CK</given-names></name></person-group>. <article-title>Genetics of Prader-Willi syndrome and Prader-Will-Like syndrome</article-title>. <source/>Ann Pediatr Endocrinol Metab. (<year>2016</year>) <volume>21</volume>:<fpage>126</fpage>–<lpage>35</lpage>. <pub-id pub-id-type="doi">10.6065/apem.2016.21.3.126</pub-id><pub-id pub-id-type="pmid">27777904</pub-id></mixed-citation>
</ref>
<ref id="B11">
<label>11.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buiting</surname><given-names>K</given-names></name></person-group>
<article-title>Prader-Willi syndrome and Angelman syndrome</article-title>. <source/>Am J Med Genet Part C Semin Med Genet. (<year>2010</year>) <volume>154</volume>:<fpage>365</fpage>–<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.c.30273</pub-id></mixed-citation>
</ref>
<ref id="B12">
<label>12.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chamberlain</surname><given-names>SJ</given-names></name><name><surname>Lalande</surname><given-names>M</given-names></name></person-group>
<article-title>Neurobiology of disease neurodevelopmental disorders involving genomic imprinting at human chromosome 15q11 – q13</article-title>. <source/>Neurobiol Dis. (<year>2010</year>) <volume>39</volume>:<fpage>13</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2010.03.011</pub-id><pub-id pub-id-type="pmid">20304067</pub-id></mixed-citation>
</ref>
<ref id="B13">
<label>13.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gunay-Aygun</surname><given-names>M</given-names></name><name><surname>Schwartz</surname><given-names>S</given-names></name><name><surname>Heeger</surname><given-names>S</given-names></name><name><surname>O'Riordan</surname><given-names>MA</given-names></name><name><surname>Cassidy</surname><given-names>SB</given-names></name></person-group>. <article-title>The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria</article-title>. <source/>Pediatrics. (<year>2001</year>) <volume>108</volume>:<fpage>e92</fpage>–<lpage>e92</lpage>. <pub-id pub-id-type="doi">10.1542/peds.108.5.e92</pub-id><pub-id pub-id-type="pmid">11694676</pub-id></mixed-citation>
</ref>
<ref id="B14">
<label>14.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>JL</given-names></name><name><surname>Lynn</surname><given-names>CH</given-names></name><name><surname>Driscoll</surname><given-names>DC</given-names></name><name><surname>Goldstone</surname><given-names>AP</given-names></name><name><surname>Gold</surname><given-names>JA</given-names></name><name><surname>Kimonis</surname><given-names>V</given-names></name><etal></etal></person-group>
<article-title>Nutritional phases in Prader-Willi syndrome</article-title>. <source/>Am J Med Genet Part A. (<year>2011</year>) <volume>155</volume>:<fpage>1040</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.33951</pub-id></mixed-citation>
</ref>
<ref id="B15">
<label>15.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butler</surname><given-names>MG</given-names></name><name><surname>Sturich</surname><given-names>J</given-names></name><name><surname>Myers</surname><given-names>SE</given-names></name><name><surname>Gold</surname><given-names>J</given-names></name><name><surname>Kimonis</surname><given-names>V</given-names></name><name><surname>Driscoll</surname><given-names>DJ</given-names></name></person-group>. <article-title>Is gestation in Prader-Willi syndrome affected by the genetic subtype?</article-title>
<source/>J Assist Reprod Genet. (<year>2009</year>) <volume>26</volume>:<fpage>461</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1007/s10815-009-9341-7</pub-id><pub-id pub-id-type="pmid">19760168</pub-id></mixed-citation>
</ref>
<ref id="B16">
<label>16.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cassidy</surname><given-names>SB</given-names></name><name><surname>Schwartz</surname><given-names>S</given-names></name><name><surname>Miller</surname><given-names>JL</given-names></name><name><surname>Driscoll</surname><given-names>DJ</given-names></name></person-group>
<article-title>Prader-Willi syndrome</article-title>. <source/>Genet Med. (<year>2012</year>) <volume>14</volume>:<fpage>10</fpage>–<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1038/gim.0b013e31822bead0</pub-id><pub-id pub-id-type="pmid">22237428</pub-id></mixed-citation>
</ref>
<ref id="B17">
<label>17.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richer</surname><given-names>LP</given-names></name><name><surname>Shevell</surname><given-names>MI</given-names></name><name><surname>Miller</surname><given-names>SP</given-names></name></person-group>. <article-title>Diagnostic profile of neonatal hypotonia: an 11-year study</article-title>. <source/>Pediatr Neurol. (<year>2001</year>) <volume>25</volume>:<fpage>32</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/S0887-8994(01)00277-6</pub-id><pub-id pub-id-type="pmid">11483393</pub-id></mixed-citation>
</ref>
<ref id="B18">
<label>18.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whittington</surname><given-names>J</given-names></name><name><surname>Holland</surname><given-names>A</given-names></name><name><surname>Webb</surname><given-names>T</given-names></name><name><surname>Butler</surname><given-names>J</given-names></name><name><surname>Clarke</surname><given-names>D</given-names></name><name><surname>Boer</surname><given-names>H</given-names></name></person-group>. <article-title>Academic underachievement by people with Prader-Willi syndrome</article-title>. <source/>J Intellect Disabil Res. (<year>2004</year>) <volume>48</volume>:<fpage>188</fpage>–<lpage>200</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2788.2004.00473.x</pub-id><pub-id pub-id-type="pmid">14723660</pub-id></mixed-citation>
</ref>
<ref id="B19">
<label>19.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jauregi</surname><given-names>J</given-names></name><name><surname>Arias</surname><given-names>C</given-names></name><name><surname>Vegas</surname><given-names>O</given-names></name><name><surname>Alén</surname><given-names>F</given-names></name><name><surname>Martinez</surname><given-names>S</given-names></name><name><surname>Copet</surname><given-names>P</given-names></name><etal></etal></person-group>. <article-title>A neuropsychological assessment of frontal cognitive functions in Prader-Willi syndrome</article-title>. <source/>J Intellect Disabil Res. (<year>2007</year>) <volume>51</volume>:<fpage>350</fpage>–<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2788.2006.00883.x</pub-id><pub-id pub-id-type="pmid">17391252</pub-id></mixed-citation>
</ref>
<ref id="B20">
<label>20.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Copet</surname><given-names>P</given-names></name><name><surname>Jauregi</surname><given-names>J</given-names></name><name><surname>Laurier</surname><given-names>V</given-names></name><name><surname>Ehlinger</surname><given-names>V</given-names></name><name><surname>Arnaud</surname><given-names>C</given-names></name><name><surname>Cobo</surname><given-names>AM</given-names></name><etal></etal></person-group>. <article-title>Cognitive profile in a large french cohort of adults with Prader-Willi syndrome: differences between genotypes</article-title>. <source/>J Intellect Disabil Res. (<year>2010</year>) <volume>54</volume>:<fpage>204</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2788.2010.01251.x</pub-id><pub-id pub-id-type="pmid">20136683</pub-id></mixed-citation>
</ref>
<ref id="B21">
<label>21.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gillett</surname><given-names>E</given-names></name><name><surname>Perez</surname><given-names>I</given-names></name></person-group>. <article-title>Disorders of sleep and ventilatory control in Prader-Willi Syndrome</article-title>. <source/>Diseases. (<year>2016</year>) <volume>4</volume>:<fpage>23</fpage>. <pub-id pub-id-type="doi">10.3390/diseases4030023</pub-id><pub-id pub-id-type="pmid">28933403</pub-id></mixed-citation>
</ref>
<ref id="B22">
<label>22.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brambilla</surname><given-names>P</given-names></name><name><surname>Crinò</surname><given-names>A</given-names></name><name><surname>Bedogni</surname><given-names>G</given-names></name><name><surname>Bosio</surname><given-names>L</given-names></name><name><surname>Cappa</surname><given-names>M</given-names></name><name><surname>Corrias</surname><given-names>A</given-names></name><etal></etal></person-group>. <article-title>Metabolic syndrome in children with Prader-Willi syndrome: the effect of obesity</article-title>. <source/>Nutr Metab Cardiovasc Dis. (<year>2011</year>) <volume>21</volume>:<fpage>269</fpage>–<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1016/j.numecd.2009.10.004</pub-id><pub-id pub-id-type="pmid">20089384</pub-id></mixed-citation>
</ref>
<ref id="B23">
<label>23.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crinò</surname><given-names>A</given-names></name><name><surname>Fintini</surname><given-names>D</given-names></name><name><surname>Bocchini</surname><given-names>S</given-names></name><name><surname>Grugni</surname><given-names>G</given-names></name></person-group>
<article-title>Diabetes, metabolic syndrome and obesity: targets and therapy dovepress obesity management in Prader-willi syndrome: current perspectives</article-title>. <source/>Diabetes Metab Syndr Obes Targets Ther. (<year>2018</year>) <volume>11</volume>:<fpage>579</fpage>–<lpage>93</lpage>. <pub-id pub-id-type="doi">10.2147/DMSO.S141352</pub-id></mixed-citation>
</ref>
<ref id="B24">
<label>24.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butler</surname><given-names>JV</given-names></name><name><surname>Whittington</surname><given-names>JE</given-names></name><name><surname>Holland</surname><given-names>AJ</given-names></name><name><surname>Boer</surname><given-names>H</given-names></name><name><surname>Clarke</surname><given-names>D</given-names></name><name><surname>Webb</surname><given-names>T</given-names></name></person-group>. <article-title>Prevalence of, and risk factors for, physical ill-health in people with Prader-Willi syndrome: a population-based study</article-title>. <source/>Dev Med Child Neurol. (<year>2002</year>) <volume>44</volume>:<fpage>248</fpage>–<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1017/S001216220100202X</pub-id><pub-id pub-id-type="pmid">11995893</pub-id></mixed-citation>
</ref>
<ref id="B25">
<label>25.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whittington</surname><given-names>JE</given-names></name><name><surname>Holland</surname><given-names>AJ</given-names></name><name><surname>Webb</surname><given-names>T</given-names></name></person-group>. <article-title>Ageing in people with Prader-Willi syndrome: mortality in the UK population cohort and morbidity in an older sample of adults</article-title>. <source/>Psychol Med. (<year>2015</year>) <volume>45</volume>:<fpage>615</fpage>–<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1017/S0033291714001755</pub-id><pub-id pub-id-type="pmid">25088280</pub-id></mixed-citation>
</ref>
<ref id="B26">
<label>26.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tauber</surname><given-names>M</given-names></name><name><surname>Cutfield</surname><given-names>W</given-names></name></person-group>. <article-title>KIGS highlights: growth hormone treatment in Prader-Willi Syndrome</article-title>. <source/>Horm Res. (<year>2007</year>) <volume>68</volume>(<issue>Suppl 5</issue>):<fpage>48</fpage>–<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1159/000110475</pub-id><pub-id pub-id-type="pmid">18174707</pub-id></mixed-citation>
</ref>
<ref id="B27">
<label>27.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grugni</surname><given-names>G</given-names></name><name><surname>Sartorio</surname><given-names>A</given-names></name><name><surname>Crinò</surname><given-names>A</given-names></name></person-group>. <article-title>Growth hormone therapy for Prader–Willi syndrome: challenges and solutions</article-title>. <source/>Ther Clin Risk Manag. (<year>2016</year>) <volume>12</volume>:<fpage>873</fpage>–<lpage>81</lpage>. <pub-id pub-id-type="doi">10.2147/TCRM.S70068</pub-id><pub-id pub-id-type="pmid">27330297</pub-id></mixed-citation>
</ref>
<ref id="B28">
<label>28.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindgren</surname><given-names>AC</given-names></name></person-group>. <article-title>Somatropin therapy for children with Prader-Willi syndrome: guidelines for use</article-title>. <source/>Treat Endocrinol. (<year>2006</year>) <volume>5</volume>:<fpage>223</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.2165/00024677-200605040-00003</pub-id><pub-id pub-id-type="pmid">16879001</pub-id></mixed-citation>
</ref>
<ref id="B29">
<label>29.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Höybye</surname><given-names>C</given-names></name></person-group>. <article-title>Five-years growth hormone (GH) treatment in adults with Prader-Willi syndrome</article-title>. <source/>Acta Paediatr. (<year>2007</year>) <volume>96</volume>:<fpage>410</fpage>–<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1111/j.1651-2227.2006.00051.x</pub-id><pub-id pub-id-type="pmid">17407467</pub-id></mixed-citation>
</ref>
<ref id="B30">
<label>30.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mogul</surname><given-names>HR</given-names></name><name><surname>Lee</surname><given-names>PDK</given-names></name><name><surname>Whitman</surname><given-names>BY</given-names></name><name><surname>Zipf</surname><given-names>WB</given-names></name><name><surname>Frey</surname><given-names>M</given-names></name><name><surname>Myers</surname><given-names>S</given-names></name><etal></etal></person-group>. <article-title>Growth hormone treatment of adults with Prader-Willi syndrome and growth hormone deficiency improves lean body mass, fractional body fat, and serum triiodothyronine without glucose impairment: results from the United States multicenter trial</article-title>. <source/>J Clin Endocrinol Metab. (<year>2008</year>) <volume>93</volume>:<fpage>1238</fpage>–<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2007-2212</pub-id><pub-id pub-id-type="pmid">18211968</pub-id></mixed-citation>
</ref>
<ref id="B31">
<label>31.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siemensma</surname><given-names>EPC</given-names></name><name><surname>Tummers-de Lind van Wijngaarden</surname><given-names>RFA</given-names></name><name><surname>Festen</surname><given-names>DAM</given-names></name><name><surname>Troeman</surname><given-names>ZCE</given-names></name><name><surname>van Alfen-van der Velden</surname><given-names>AAEM</given-names></name><name><surname>Otten</surname><given-names>BJ</given-names></name><etal></etal></person-group>. <article-title>Beneficial effects of growth hormone treatment on cognition in children with Prader-Willi syndrome: a randomized controlled trial and longitudinal study</article-title>. <source/>J Clin Endocrinol Metab. (<year>2012</year>) <volume>97</volume>:<fpage>2307</fpage>–<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2012-1182</pub-id><pub-id pub-id-type="pmid">22508707</pub-id></mixed-citation>
</ref>
<ref id="B32">
<label>32.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berini</surname><given-names>J</given-names></name><name><surname>Spica Russotto</surname><given-names>V</given-names></name><name><surname>Castelnuovo</surname><given-names>P</given-names></name><name><surname>Di Candia</surname><given-names>S</given-names></name><name><surname>Gargantini</surname><given-names>L</given-names></name><name><surname>Grugni</surname><given-names>G</given-names></name><etal></etal></person-group>. <article-title>Growth hormone therapy and respiratory disorders: long-term follow-up in PWS children</article-title>. <source/>J Clin Endocrinol Metab. (<year>2013</year>) <volume>98</volume>:<fpage>E1516</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2013-1831</pub-id><pub-id pub-id-type="pmid">23894156</pub-id></mixed-citation>
</ref>
<ref id="B33">
<label>33.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deal</surname><given-names>CL</given-names></name><name><surname>Tony</surname><given-names>M</given-names></name><name><surname>Höybye</surname><given-names>C</given-names></name><name><surname>Allen</surname><given-names>DB</given-names></name><name><surname>Tauber</surname><given-names>M</given-names></name><name><surname>Christiansen</surname><given-names>JS</given-names></name><etal></etal></person-group>. <article-title>Growth hormone research society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome</article-title>. <source/>J Clin Endocrinol Metab. (<year>2013</year>) <volume>98</volume>:<fpage>E1072</fpage>–<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2012-3888</pub-id><pub-id pub-id-type="pmid">23543664</pub-id></mixed-citation>
</ref>
<ref id="B34">
<label>34.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dykens</surname><given-names>EM</given-names></name><name><surname>Roof</surname><given-names>E</given-names></name><name><surname>Hunt-Hawkins</surname><given-names>H</given-names></name></person-group>. <article-title>Cognitive and adaptive advantages of growth hormone treatment in children with Prader-Willi syndrome</article-title>. <source/>J Child Psychol Psychiatry Allied Discip. (<year>2017</year>) <volume>58</volume>:<fpage>64</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1111/jcpp.12601</pub-id><pub-id pub-id-type="pmid">27481444</pub-id></mixed-citation>
</ref>
<ref id="B35">
<label>35.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crinò</surname><given-names>A</given-names></name><name><surname>Schiaffini</surname><given-names>R</given-names></name><name><surname>Ciampalini</surname><given-names>P</given-names></name><name><surname>Spera</surname><given-names>S</given-names></name><name><surname>Beccaria</surname><given-names>L</given-names></name><name><surname>Benzi</surname><given-names>F</given-names></name><etal></etal></person-group>. <article-title>Hypogonadism and pubertal development in Prader-Willi syndrome</article-title>. <source/>Eur J Pediatr. (<year>2003</year>) <volume>162</volume>:<fpage>327</fpage>–<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1007/s00431-002-1132-4</pub-id><pub-id pub-id-type="pmid">12692714</pub-id></mixed-citation>
</ref>
<ref id="B36">
<label>36.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heksch</surname><given-names>R</given-names></name><name><surname>Kamboj</surname><given-names>M</given-names></name><name><surname>Anglin</surname><given-names>K</given-names></name><name><surname>Obrynba</surname><given-names>K</given-names></name></person-group>. <article-title>Review of Prader-Willi syndrome: the endocrine approach</article-title>. <source/>Transl Pediatr. (<year>2017</year>) <volume>6</volume>:<fpage>274</fpage>–<lpage>85</lpage>. <pub-id pub-id-type="doi">10.21037/tp.2017.09.04</pub-id><pub-id pub-id-type="pmid">29184809</pub-id></mixed-citation>
</ref>
<ref id="B37">
<label>37.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muscogiuri</surname><given-names>G</given-names></name><name><surname>Formoso</surname><given-names>G</given-names></name><name><surname>Pugliese</surname><given-names>G</given-names></name><name><surname>Ruggeri</surname><given-names>RM</given-names></name><name><surname>Scarano</surname><given-names>E</given-names></name><name><surname>Colao</surname><given-names>A</given-names></name></person-group>. <article-title>Prader- Willi syndrome: an uptodate on endocrine and metabolic complications</article-title>. <source/>Rev Endocr Metab Disord. (<year>2019</year>) <volume>20</volume>:<fpage>239</fpage>–<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1007/s11154-019-09502-2</pub-id><pub-id pub-id-type="pmid">31065942</pub-id></mixed-citation>
</ref>
<ref id="B38">
<label>38.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tauber</surname><given-names>M</given-names></name><name><surname>Barbeau</surname><given-names>C</given-names></name><name><surname>Jouret</surname><given-names>B</given-names></name><name><surname>Pienkowski</surname><given-names>C</given-names></name><name><surname>Malzac</surname><given-names>P</given-names></name><name><surname>Moncla</surname><given-names>A</given-names></name><etal></etal></person-group>. <article-title>Auxological and endocrine evolution of 28 children with Prader-Willi syndrome: effect of GH therapy in 14 children</article-title>. <source/>Horm Res Paediatr. (<year>2000</year>) <volume>53</volume>:<fpage>279</fpage>–<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1159/000053184</pub-id><pub-id pub-id-type="pmid">11146368</pub-id></mixed-citation>
</ref>
<ref id="B39">
<label>39.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corrias</surname><given-names>A</given-names></name><name><surname>Grugni</surname><given-names>G</given-names></name><name><surname>Crinò</surname><given-names>A</given-names></name><name><surname>Di Candia</surname><given-names>S</given-names></name><name><surname>Chiabotto</surname><given-names>P</given-names></name><name><surname>Cogliardi</surname><given-names>A</given-names></name><etal></etal></person-group>. <article-title>Assessment of central adrenal insufficiency in children and adolescents with Prader-Willi syndrome</article-title>. <source/>Clin Endocrinol. (<year>2012</year>) <volume>76</volume>:<fpage>843</fpage>–<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2265.2011.04313.x</pub-id><pub-id pub-id-type="pmid">22150958</pub-id></mixed-citation>
</ref>
<ref id="B40">
<label>40.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beauloye</surname><given-names>V</given-names></name><name><surname>Dhondt</surname><given-names>K</given-names></name><name><surname>Buysse</surname><given-names>W</given-names></name><name><surname>Nyakasane</surname><given-names>A</given-names></name><name><surname>Zech</surname><given-names>F</given-names></name><name><surname>De Schepper</surname><given-names>J</given-names></name><etal></etal></person-group>
<article-title>Evaluation of the hypothalamic-pituitary-adrenal axis and its relationship with central respiratory dysfunction in children with Prader-Willi syndrome rare endocrinological diseases</article-title>. <source/>Orphanet J Rare Dis. (<year>2015</year>) <volume>10</volume>:<fpage>4</fpage>–<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1186/s13023-015-0312-z</pub-id><pub-id pub-id-type="pmid">25608574</pub-id></mixed-citation>
</ref>
<ref id="B41">
<label>41.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grugni</surname><given-names>G</given-names></name><name><surname>Beccaria</surname><given-names>L</given-names></name><name><surname>Corrias</surname><given-names>A</given-names></name><name><surname>Crinò</surname><given-names>A</given-names></name><name><surname>Cappa</surname><given-names>M</given-names></name><name><surname>De Medici</surname><given-names>C</given-names></name><etal></etal></person-group>. <article-title>Central adrenal insufficiency in young adults with Prader-Willi Syndrome</article-title>. <source/>Clin Endocrinol. (<year>2013</year>) <volume>79</volume>:<fpage>371</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1111/cen.12150</pub-id><pub-id pub-id-type="pmid">23311724</pub-id></mixed-citation>
</ref>
<ref id="B42">
<label>42.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>A</given-names></name><name><surname>Hung</surname><given-names>D</given-names></name></person-group>
<article-title>The dilemma of diagnostic testing for Prader-Willi syndrome</article-title>. <source/>Transl Pediatr. (<year>2017</year>) <volume>5</volume>:<fpage>46</fpage>–<lpage>56</lpage>. <pub-id pub-id-type="doi">10.21037/tp.2016.07.04</pub-id></mixed-citation>
</ref>
<ref id="B43">
<label>43.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glenn</surname><given-names>CC</given-names></name><name><surname>Saitoh</surname><given-names>S</given-names></name><name><surname>Jong</surname><given-names>MTC</given-names></name><name><surname>Filbrandt</surname><given-names>MM</given-names></name><name><surname>Surti</surname><given-names>U</given-names></name><name><surname>Driscoll</surname><given-names>DJ</given-names></name><etal></etal></person-group>. <article-title>Gene structure, DNA methylation, and imprinted expression of the human SNRPN gene</article-title>. <source/>Am J Hum Genet. (<year>1996</year>) <volume>58</volume>:<fpage>335</fpage>–<lpage>46</lpage>. <pub-id pub-id-type="pmid">8571960</pub-id></mixed-citation>
</ref>
<ref id="B44">
<label>44.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohta</surname><given-names>T</given-names></name><name><surname>Gray</surname><given-names>TA</given-names></name><name><surname>Rogan</surname><given-names>PK</given-names></name><name><surname>Buiting</surname><given-names>K</given-names></name><name><surname>Gabriel</surname><given-names>JM</given-names></name><name><surname>Saitoh</surname><given-names>S</given-names></name><etal></etal></person-group>. <article-title>Imprinting-mutation mechanisms in Prader-Willi Syndrome</article-title>. <source/>AGHG. (<year>1999</year>) <volume>64</volume>:<fpage>397</fpage>–<lpage>413</lpage>. <pub-id pub-id-type="doi">10.1086/302233</pub-id><pub-id pub-id-type="pmid">9973278</pub-id></mixed-citation>
</ref>
<ref id="B45">
<label>45.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yazdi</surname><given-names>PG</given-names></name><name><surname>Su</surname><given-names>H</given-names></name><name><surname>Ghimbovschi</surname><given-names>S</given-names></name><name><surname>Fan</surname><given-names>W</given-names></name><name><surname>Coskun</surname><given-names>PE</given-names></name><name><surname>Nalbandian</surname><given-names>A</given-names></name><etal></etal></person-group>. <article-title>Differential gene expression reveals mitochondrial dysfunction in an imprinting center deletion mouse model of prader-willi syndrome</article-title>. <source/>Clin Transl Sci. (<year>2013</year>) <volume>6</volume>:<fpage>347</fpage>–<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1111/cts.12083</pub-id><pub-id pub-id-type="pmid">24127921</pub-id></mixed-citation>
</ref>
<ref id="B46">
<label>46.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galiveti</surname><given-names>CR</given-names></name><name><surname>Raabe</surname><given-names>CA</given-names></name><name><surname>Konthur</surname><given-names>Z</given-names></name><name><surname>Rozhdestvensky</surname><given-names>TS</given-names></name></person-group>. <article-title>Differential regulation of non-protein coding RNAs from Prader-Willi Syndrome locus</article-title>. <source/>Sci Rep. (<year>2014</year>) <volume>4</volume>:<fpage>6445</fpage>. <pub-id pub-id-type="doi">10.1038/srep06445</pub-id><pub-id pub-id-type="pmid">25246219</pub-id></mixed-citation>
</ref>
<ref id="B47">
<label>47.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butler</surname><given-names>MG</given-names></name><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Marshall</surname><given-names>JD</given-names></name><name><surname>Naggert</surname><given-names>JK</given-names></name><name><surname>Rethmeyer</surname><given-names>JA</given-names></name><name><surname>Gunewardena</surname><given-names>SS</given-names></name><etal></etal></person-group>
<article-title>Coding and noncoding expression patterns associated with rare obesity-related disorders: Prader-Willi and Alstrom syndromes</article-title>. <source/>Adv Genomics Genet. (<year>2015</year>) <volume>50</volume>:<fpage>53</fpage>–<lpage>75</lpage>. <pub-id pub-id-type="doi">10.2147/AGG.S74598</pub-id></mixed-citation>
</ref>
<ref id="B48">
<label>48.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koufaris</surname><given-names>C</given-names></name><name><surname>Alexandrou</surname><given-names>A</given-names></name><name><surname>Papaevripidou</surname><given-names>I</given-names></name><name><surname>Alexandrou</surname><given-names>I</given-names></name><name><surname>Christophidou-Anastasiadou</surname><given-names>V</given-names></name><name><surname>Sismani</surname><given-names>C</given-names></name></person-group>. <article-title>Deletion of SNURF/SNRPN U1B and U1B<sup>*</sup> upstream exons in a child with developmental delay and excessive weight</article-title>. <source/>J Genet. (<year>2016</year>) <volume>95</volume>:<fpage>621</fpage>–<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1007/s12041-016-0666-6</pub-id><pub-id pub-id-type="pmid">27659333</pub-id></mixed-citation>
</ref>
<ref id="B49">
<label>49.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bittel</surname><given-names>DC</given-names></name><name><surname>Butler</surname><given-names>MG</given-names></name></person-group>. <article-title>Prader-Willi syndrome: clinical genetics, cytogenetics and molecular biology</article-title>. <source/>Expert Rev Mol Med. (<year>2005</year>) <volume>7</volume>:<fpage>1</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1017/S1462399405009531</pub-id><pub-id pub-id-type="pmid">16038620</pub-id></mixed-citation>
</ref>
<ref id="B50">
<label>50.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christian</surname><given-names>SL</given-names></name><name><surname>Robinson</surname><given-names>WP</given-names></name><name><surname>Huang</surname><given-names>B</given-names></name><name><surname>Mutirangura</surname><given-names>A</given-names></name><name><surname>Line</surname><given-names>MR</given-names></name><name><surname>Nakao</surname><given-names>M</given-names></name><etal></etal></person-group>. <article-title>Molecular characterization of two proximal deletion breakpoint regions in both Prader-Willi and Angelman syndrome patients</article-title>. <source/>Am J Hum Genet. (<year>1995</year>) <volume>57</volume>:<fpage>40</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="pmid">7611294</pub-id></mixed-citation>
</ref>
<ref id="B51">
<label>51.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartin</surname><given-names>SN</given-names></name><name><surname>Hossain</surname><given-names>WA</given-names></name><name><surname>Francis</surname><given-names>D</given-names></name><name><surname>Godler</surname><given-names>DE</given-names></name><name><surname>Barkataki</surname><given-names>S</given-names></name><name><surname>Butler</surname><given-names>MG</given-names></name></person-group>. <article-title>Analysis of the Prader–Willi syndrome imprinting center using droplet digital PCR and next-generation whole-exome sequencing</article-title>. <source/>Mol Genet Genomic Med. (<year>2019</year>) <volume>7</volume>:<fpage>1</fpage>–<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1002/mgg3.575</pub-id><pub-id pub-id-type="pmid">31293106</pub-id></mixed-citation>
</ref>
<ref id="B52">
<label>52.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glenn</surname><given-names>CC</given-names></name><name><surname>Driscoll</surname><given-names>DJ</given-names></name><name><surname>Yang</surname><given-names>TP</given-names></name><name><surname>Nicholls</surname><given-names>RD</given-names></name></person-group>. <article-title>Genomic imprinting: potential function and mechanisms revealed by the Prader-Willi and Angelman syndromes</article-title>. <source/>Mol Hum Reprod. (<year>1997</year>) <volume>3</volume>:<fpage>321</fpage>–<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1093/molehr/3.4.321</pub-id><pub-id pub-id-type="pmid">9237260</pub-id></mixed-citation>
</ref>
<ref id="B53">
<label>53.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kosaki</surname><given-names>K</given-names></name><name><surname>McGinniss</surname><given-names>MJ</given-names></name><name><surname>Veraksa</surname><given-names>AN</given-names></name><name><surname>McGinnis</surname><given-names>WJ</given-names></name><name><surname>Jones</surname><given-names>KL</given-names></name></person-group>. <article-title>Prader-Willi and Angelman syndromes: diagnosis with a bisulfite-treated methylation-specific PCR method</article-title>. <source/>Am J Med Genet. (<year>1997</year>) <volume>73</volume>:<fpage>308</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1096-8628(19971219)73:3&lt;308::AID-AJMG15&gt;3.0.CO;2-N</pub-id><pub-id pub-id-type="pmid">9415690</pub-id></mixed-citation>
</ref>
<ref id="B54">
<label>54.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Botezatu</surname><given-names>A</given-names></name><name><surname>Puiu</surname><given-names>M</given-names></name><name><surname>Cucu</surname><given-names>N</given-names></name><name><surname>Diaconu</surname><given-names>CC</given-names></name><name><surname>Badiu</surname><given-names>C</given-names></name><name><surname>Arsene</surname><given-names>C</given-names></name><etal></etal></person-group>. <article-title>Comparative molecular approaches in Prader-Willi syndrome diagnosis</article-title>. <source/>Gene. (<year>2016</year>) <volume>575</volume>:<fpage>353</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.gene.2015.08.058</pub-id><pub-id pub-id-type="pmid">26335514</pub-id></mixed-citation>
</ref>
<ref id="B55">
<label>55.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bittel</surname><given-names>DC</given-names></name><name><surname>Kibiryeva</surname><given-names>N</given-names></name><name><surname>Butler</surname><given-names>MG</given-names></name></person-group>. <article-title>Methylation-specific multiplex ligation-dependent probe amplification analysis of subjects with chromosome 15 abnormalities</article-title>. <source/>Genet Test. (<year>2007</year>) <volume>11</volume>:<fpage>467</fpage>–<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1089/gte.2007.0061</pub-id><pub-id pub-id-type="pmid">18294067</pub-id></mixed-citation>
</ref>
<ref id="B56">
<label>56.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henkhaus</surname><given-names>RS</given-names></name><name><surname>Kim</surname><given-names>SJ</given-names></name><name><surname>Kimonis</surname><given-names>VE</given-names></name><name><surname>Gold</surname><given-names>J-A</given-names></name><name><surname>Dykens</surname><given-names>EM</given-names></name><name><surname>Driscoll</surname><given-names>DJ</given-names></name><etal></etal></person-group>. <article-title>Methylation-specific multiplex ligation-dependent probe amplification and identification of deletion genetic subtypes in Prader-Willi syndrome</article-title>. <source/>Genet Test Mol Biomarkers. (<year>2011</year>) <volume>16</volume>:<fpage>178</fpage>–<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1089/gtmb.2011.0115</pub-id><pub-id pub-id-type="pmid">21977908</pub-id></mixed-citation>
</ref>
<ref id="B57">
<label>57.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>HE</given-names></name><name><surname>Hall</surname><given-names>VJ</given-names></name><name><surname>Cross</surname><given-names>NCP</given-names></name></person-group>. <article-title>Methylation-sensitive high-resolution melting-curve analysis of the SNRPN gene as a diagnostic screen for Prader-Willi and Angelman syndromes</article-title>. <source/>Clin Chem. (<year>2007</year>) <volume>53</volume>:<fpage>1960</fpage>–<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1373/clinchem.2007.093351</pub-id><pub-id pub-id-type="pmid">17890436</pub-id></mixed-citation>
</ref>
<ref id="B58">
<label>58.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferreira</surname><given-names>IR</given-names></name><name><surname>Darleans dos Santos Cunha</surname><given-names>W</given-names></name><name><surname>Henrique Ferreira Gomes</surname><given-names>L</given-names></name><name><surname>Azevedo Cintra</surname><given-names>H</given-names></name><name><surname>Lopes Cabral Guimarães Fonseca</surname><given-names>L</given-names></name><name><surname>Ferreira Bastos</surname><given-names>E</given-names></name><etal></etal></person-group>
<article-title>A rapid and accurate methylation-sensitive high-resolution melting analysis assay for the diagnosis of Prader Willi and Angelman patients</article-title>. <source/>Mol Genet Genomic Med. (<year>2019</year>) <volume>7</volume>:<fpage>1</fpage>–<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1002/mgg3.637</pub-id><pub-id pub-id-type="pmid">31293106</pub-id></mixed-citation>
</ref>
<ref id="B59">
<label>59.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hawkey</surname><given-names>CJ</given-names></name><name><surname>Smithies</surname><given-names>A</given-names></name></person-group>. <article-title>The Prader-Willi syndrome with a 15/15 translocation</article-title>. Case report and review of the literature. <source/>J Med Genet. (<year>1996</year>) <volume>13</volume>:<fpage>152</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.13.2.152</pub-id><pub-id pub-id-type="pmid">933113</pub-id></mixed-citation>
</ref>
<ref id="B60">
<label>60.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>A</given-names></name><name><surname>Lindeman</surname><given-names>R</given-names></name><name><surname>Volpato</surname><given-names>F</given-names></name><name><surname>Kearney</surname><given-names>A</given-names></name><name><surname>White</surname><given-names>S</given-names></name><name><surname>Haan</surname><given-names>E</given-names></name><etal></etal></person-group>. <article-title>A <italic>de novo</italic> unbalanced reciprocal translocation identified as paternal in origin in the Prader-Willi syndrome</article-title>. <source/>Hum Genet. (<year>1991</year>) <volume>86</volume>:<fpage>534</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1007/BF00194651</pub-id><pub-id pub-id-type="pmid">2016095</pub-id></mixed-citation>
</ref>
<ref id="B61">
<label>61.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>WP</given-names></name><name><surname>Dutly</surname><given-names>F</given-names></name><name><surname>Nicholls</surname><given-names>RD</given-names></name><name><surname>Bernasconi</surname><given-names>F</given-names></name><name><surname>Pefiaherrera</surname><given-names>M</given-names></name><name><surname>Michaelis</surname><given-names>RC</given-names></name><etal></etal></person-group>. <article-title>The mechanisms involved in formation of deletions</article-title>. <source/>J Med Genet. (<year>1998</year>) <volume>35</volume>:<fpage>130</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.35.2.130</pub-id><pub-id pub-id-type="pmid">9580159</pub-id></mixed-citation>
</ref>
<ref id="B62">
<label>62.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuslich</surname><given-names>CD</given-names></name><name><surname>Kobori</surname><given-names>JA</given-names></name><name><surname>Mohapatra</surname><given-names>G</given-names></name><name><surname>Gregorio-King</surname><given-names>C</given-names></name><name><surname>Donlon</surname><given-names>TA</given-names></name></person-group>. <article-title>Prader-Willi syndrome is caused by disruption of the SNRPN gene</article-title>. <source/>Am J Hum Genet. (<year>1999</year>) <volume>64</volume>:<fpage>70</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1086/302177</pub-id><pub-id pub-id-type="pmid">9915945</pub-id></mixed-citation>
</ref>
<ref id="B63">
<label>63.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flori</surname><given-names>E</given-names></name><name><surname>Biancalana</surname><given-names>V</given-names></name><name><surname>Girard-Lemaire</surname><given-names>F</given-names></name><name><surname>Favre</surname><given-names>R</given-names></name><name><surname>Flori</surname><given-names>J</given-names></name><name><surname>Doray</surname><given-names>B</given-names></name><etal></etal></person-group>
<article-title>Difficulties of genetic counselling and prenatal diagnosis in a consanguineous couple segregating for the same translocation (14;15) (q11;q13) and at risk for Prader-Willi and Angelman syndromes</article-title>. <source/>Eur J Hum Genet. (<year>2004</year>) <volume>12</volume>:<fpage>181</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1038/sj.ejhg.5201134</pub-id><pub-id pub-id-type="pmid">14694357</pub-id></mixed-citation>
</ref>
<ref id="B64">
<label>64.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SJ</given-names></name><name><surname>Miller</surname><given-names>JL</given-names></name><name><surname>Kuipers</surname><given-names>PJ</given-names></name><name><surname>German</surname><given-names>JR</given-names></name><name><surname>Beaudet</surname><given-names>AL</given-names></name><name><surname>Sahoo</surname><given-names>T</given-names></name><etal></etal></person-group>. <article-title>Unique and atypical deletions in Prader-Willi syndrome reveal distinct phenotypes</article-title>. <source/>Eur J Hum Genet. (<year>2012</year>) <volume>20</volume>:<fpage>283</fpage>–<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1038/ejhg.2011.187</pub-id><pub-id pub-id-type="pmid">22045295</pub-id></mixed-citation>
</ref>
<ref id="B65">
<label>65.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yip</surname><given-names>MY</given-names></name></person-group>. <article-title>Uniparental disomy in Robertsonian translocations: strategies for uniparental disomy testing</article-title>. <source/>Transl Pediatr. (<year>2014</year>) <volume>3</volume>:<fpage>98</fpage>–<lpage>107</lpage>. <pub-id pub-id-type="doi">10.3978/j.issn.2224-4336.2014.03.03</pub-id><pub-id pub-id-type="pmid">26835328</pub-id></mixed-citation>
</ref>
<ref id="B66">
<label>66.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santoro</surname><given-names>SL</given-names></name><name><surname>Hashimoto</surname><given-names>S</given-names></name><name><surname>McKinney</surname><given-names>A</given-names></name><name><surname>Mihalic Mosher</surname><given-names>T</given-names></name><name><surname>Pyatt</surname><given-names>R</given-names></name><name><surname>Reshmi</surname><given-names>SC</given-names></name><etal></etal></person-group>. <article-title>Assessing the clinical utility of SNP microarray for Prader-Willi syndrome due to uniparental disomy</article-title>. <source/>Cytogenet Genome Res. (<year>2017</year>) <volume>152</volume>:<fpage>105</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1159/000478921</pub-id><pub-id pub-id-type="pmid">28746920</pub-id></mixed-citation>
</ref>
<ref id="B67">
<label>67.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beygo</surname><given-names>J</given-names></name><name><surname>Buiting</surname><given-names>K</given-names></name><name><surname>Ramsden</surname><given-names>SC</given-names></name><name><surname>Ellis</surname><given-names>R</given-names></name><name><surname>Clayton-Smith</surname><given-names>J</given-names></name><name><surname>Kanber</surname><given-names>D</given-names></name></person-group>
<article-title>Update of the EMQN/ACGS best practice guidelines for molecular analysis of Prader-Willi and Angelman syndromes</article-title>. <source/>Eur J Hum Genet. (<year>2019</year>) <volume>15</volume>:<fpage>1326</fpage>–<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1038/s41431-019-0435-0</pub-id></mixed-citation>
</ref>
<ref id="B68">
<label>68.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torrado</surname><given-names>M</given-names></name><name><surname>Araoz</surname><given-names>V</given-names></name><name><surname>Baialardo</surname><given-names>E</given-names></name><name><surname>Abraldes</surname><given-names>K</given-names></name><name><surname>Mazza</surname><given-names>C</given-names></name><name><surname>Krochik</surname><given-names>G</given-names></name><etal></etal></person-group>. <article-title>Clinical-etiologic correlation in children with Prader-Willi syndrome (PWS): an interdisciplinary study</article-title>. <source/>Am J Med Genet Part A. (<year>2007</year>) <volume>143A</volume>:<fpage>460</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.31520</pub-id><pub-id pub-id-type="pmid">17163531</pub-id></mixed-citation>
</ref>
<ref id="B69">
<label>69.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butler</surname><given-names>MG</given-names></name><name><surname>Bittel</surname><given-names>DC</given-names></name><name><surname>Bittel</surname><given-names>N</given-names></name><name><surname>Talebizadeh</surname><given-names>KZ</given-names></name><name><surname>Thompson</surname><given-names>T</given-names></name></person-group>. <article-title>Behavioral differences among subjects with Prader-Willi Syndrome and type I or type II deletion and maternal disomy</article-title>. <source/>Pediatrics. (<year>2004</year>) <volume>113</volume>:<fpage>565</fpage>–<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1542/peds.113.3.565</pub-id><pub-id pub-id-type="pmid">14993551</pub-id></mixed-citation>
</ref>
<ref id="B70">
<label>70.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartley</surname><given-names>SL</given-names></name><name><surname>MacLean</surname><given-names>WE</given-names></name><name><surname>Butler</surname><given-names>MG</given-names></name><name><surname>Zarcone</surname><given-names>J</given-names></name><name><surname>Thompson</surname><given-names>T</given-names></name></person-group>
<article-title>Maladaptive behaviors and risk factors among the genetic subtypes of Prader-Willi syndrome</article-title>. <source/>Am J Med Genet Part A. (<year>2005</year>) <volume>136A</volume>:<fpage>140</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.30771</pub-id></mixed-citation>
</ref>
<ref id="B71">
<label>71.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Descheemaeker</surname><given-names>MJ</given-names></name><name><surname>Govers</surname><given-names>V</given-names></name><name><surname>Vermeulen</surname><given-names>P</given-names></name><name><surname>Fryns</surname><given-names>JP</given-names></name></person-group>
<article-title>Pervasive developmental disorders in Prader–Willi syndrome: the Leuven experience in 59 subjects and controls</article-title>. <source/>Am J Med Genet Part A. (<year>2006</year>) <volume>140A</volume>:<fpage>1136</fpage>–<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.31235</pub-id></mixed-citation>
</ref>
<ref id="B72">
<label>72.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dykens</surname><given-names>EM</given-names></name></person-group>. <article-title>Are Jigsaw Puzzle skills ‘spared' in persons with Prader-Willi syndrome?</article-title>
<source/>J Child Psychol Psychiatry. (<year>2002</year>) <volume>43</volume>:<fpage>343</fpage>–<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1111/1469-7610.00025</pub-id><pub-id pub-id-type="pmid">11944876</pub-id></mixed-citation>
</ref>
<ref id="B73">
<label>73.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whittington</surname><given-names>J</given-names></name><name><surname>Holland</surname><given-names>A</given-names></name><name><surname>Webb</surname><given-names>T</given-names></name><name><surname>Butler</surname><given-names>J</given-names></name><name><surname>Clarke</surname><given-names>D</given-names></name><name><surname>Boer</surname><given-names>H</given-names></name></person-group>. <article-title>Cognitive abilities and genotype in a population-based sample of people with Prader-Willi syndrome</article-title>. <source/>J Intellect Disabil Res. (<year>2004</year>) <volume>48</volume>:<fpage>172</fpage>–<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2788.2004.00556.x</pub-id><pub-id pub-id-type="pmid">14723659</pub-id></mixed-citation>
</ref>
<ref id="B74">
<label>74.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Zhan</surname><given-names>G</given-names></name><name><surname>Ding</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Ma</surname><given-names>D</given-names></name><name><surname>Huang</surname><given-names>G</given-names></name><etal></etal></person-group>. <article-title>Psychiatric illness and intellectual disability in the Prader–Willi syndrome with different molecular defects - a meta analysis</article-title>. <source/>PLoS ONE. (<year>2013</year>) <volume>8</volume>:<fpage>e72640</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0072640</pub-id><pub-id pub-id-type="pmid">23967326</pub-id></mixed-citation>
</ref>
<ref id="B75">
<label>75.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dykens</surname><given-names>EM</given-names></name><name><surname>Roof</surname><given-names>E</given-names></name><name><surname>Hunt-Hawkins</surname><given-names>H</given-names></name><name><surname>Dankner</surname><given-names>N</given-names></name><name><surname>Lee</surname><given-names>EB</given-names></name><name><surname>Shivers</surname><given-names>CM</given-names></name><etal></etal></person-group>. <article-title>Diagnoses and characteristics of autism spectrum disorders in children with Prader-Willi syndrome</article-title>. <source/>J Neurodev Disord. (<year>2017</year>) <volume>9</volume>:<fpage>18</fpage>. <pub-id pub-id-type="doi">10.1186/s11689-017-9200-2</pub-id><pub-id pub-id-type="pmid">28592997</pub-id></mixed-citation>
</ref>
<ref id="B76">
<label>76.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jong</surname><given-names>MTC</given-names></name><name><surname>Gray</surname><given-names>TA</given-names></name><name><surname>Ji</surname><given-names>Y</given-names></name><name><surname>Glenn</surname><given-names>CC</given-names></name><name><surname>Saitoh</surname><given-names>S</given-names></name><name><surname>Driscoll</surname><given-names>DJ</given-names></name><etal></etal></person-group>. <article-title>A novel imprinted gene, encoding a RING Zinc-finger protein, and overlapping antisense transcript in the Prader-Willi syndrome critical region</article-title>. <source/>Hum Mol Genet. (<year>1999</year>) <volume>8</volume>:<fpage>783</fpage>–<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/8.5.783</pub-id><pub-id pub-id-type="pmid">10196367</pub-id></mixed-citation>
</ref>
<ref id="B77">
<label>77.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valadares</surname><given-names>LP</given-names></name><name><surname>Meireles</surname><given-names>CG</given-names></name><name><surname>De Toledo</surname><given-names>IP</given-names></name><name><surname>Santarem de Oliveira</surname><given-names>R</given-names></name><name><surname>Gonçalves de Castro</surname><given-names>LC</given-names></name><name><surname>Abreu</surname><given-names>AP</given-names></name><etal></etal></person-group>. <article-title><italic>MKRN3</italic> mutations in central precocious puberty: a systematic review and meta-analysis</article-title>. <source/>J Endocr Soc. (<year>2019</year>) <volume>3</volume>:<fpage>979</fpage>–<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1210/js.2019-00041</pub-id><pub-id pub-id-type="pmid">31041429</pub-id></mixed-citation>
</ref>
<ref id="B78">
<label>78.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abreu</surname><given-names>AP</given-names></name><name><surname>Delanie</surname><given-names>BM</given-names></name><name><surname>Brito</surname><given-names>VN</given-names></name><name><surname>Kaiser</surname><given-names>UB</given-names></name><name><surname>Latronico</surname><given-names>AC</given-names></name></person-group>. <article-title>A new pathway in the control of the initiation of puberty: the <italic>MKRN3</italic> gene</article-title>. <source/>J Mol Endocrinol. (<year>2015</year>) <volume>54</volume>:<fpage>R131</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1530/JME-14-0315</pub-id><pub-id pub-id-type="pmid">25957321</pub-id></mixed-citation>
</ref>
<ref id="B79">
<label>79.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macedo</surname><given-names>DB</given-names></name><name><surname>Abreu</surname><given-names>AP</given-names></name><name><surname>Reis</surname><given-names>ACS</given-names></name><name><surname>Montenegro</surname><given-names>LR</given-names></name><name><surname>Dauber</surname><given-names>A</given-names></name><name><surname>Beneduzzi</surname><given-names>D</given-names></name><etal></etal></person-group>. <article-title>Central precocious puberty that appears to be sporadic caused by paternally inherited mutations in the imprinted gene makorin ring finger 3</article-title>. <source/>J Clin Endocrinol Metab. (<year>2014</year>) <volume>99</volume>:<fpage>E1097</fpage>–<lpage>103</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2013-3126</pub-id><pub-id pub-id-type="pmid">24628548</pub-id></mixed-citation>
</ref>
<ref id="B80">
<label>80.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schreiner</surname><given-names>F</given-names></name><name><surname>Gohlke</surname><given-names>B</given-names></name><name><surname>Hamm</surname><given-names>M</given-names></name><name><surname>Korsch</surname><given-names>E</given-names></name><name><surname>Woelfle</surname><given-names>J</given-names></name></person-group>. <article-title><italic>MKRN3</italic> mutations in familial central precocious puberty</article-title>. <source/>Horm Res Paediatr. (<year>2014</year>) <volume>82</volume>:<fpage>122</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1159/000362815</pub-id><pub-id pub-id-type="pmid">25011910</pub-id></mixed-citation>
</ref>
<ref id="B81">
<label>81.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Settas</surname><given-names>N</given-names></name><name><surname>Dacou-Voutetakis</surname><given-names>C</given-names></name><name><surname>Karantza</surname><given-names>M</given-names></name><name><surname>Kanaka-Gantenbein</surname><given-names>C</given-names></name><name><surname>Chrousos</surname><given-names>GP</given-names></name><name><surname>Voutetakis</surname><given-names>A</given-names></name></person-group>. <article-title>Central precocious puberty in a girl and early puberty in her brother caused by a novel mutation in the <italic>MKRN3</italic> gene</article-title>. <source/>J Clin Endocrinol Metab. (<year>2014</year>) <volume>99</volume>:<fpage>E647</fpage>–<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2013-4084</pub-id><pub-id pub-id-type="pmid">24438377</pub-id></mixed-citation>
</ref>
<ref id="B82">
<label>82.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaaf</surname><given-names>CP</given-names></name><name><surname>Gonzalez-Garay</surname><given-names>ML</given-names></name><name><surname>Xia</surname><given-names>F</given-names></name><name><surname>Potocki</surname><given-names>L</given-names></name><name><surname>Gripp</surname><given-names>KW</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><etal></etal></person-group>. <article-title>Truncating mutations of <italic>MAGEL2</italic> cause Prader-Willi phenotypes and autism</article-title>. <source/>Nat Genet. (<year>2013</year>) <volume>45</volume>:<fpage>1405</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1038/ng.2776</pub-id><pub-id pub-id-type="pmid">24076603</pub-id></mixed-citation>
</ref>
<ref id="B83">
<label>83.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bischof</surname><given-names>JM</given-names></name><name><surname>Stewart</surname><given-names>LC</given-names></name><name><surname>Wevrick</surname><given-names>R</given-names></name></person-group>. <article-title>Inactivation of the mouse <italic>MAGEL2</italic> gene results in growth abnormalities similar to Prader-Willi syndrome</article-title>. <source/>Hum Mol Genet. (<year>2007</year>) <volume>16</volume>:<fpage>2713</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddm225</pub-id><pub-id pub-id-type="pmid">17728320</pub-id></mixed-citation>
</ref>
<ref id="B84">
<label>84.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devos</surname><given-names>J</given-names></name><name><surname>Weselake</surname><given-names>SV</given-names></name><name><surname>Wevrick</surname><given-names>R</given-names></name></person-group>. <article-title><italic>MAGEL2</italic>, a Prader-Willi syndrome candidate gene, modulates the activities of circadian rhythm proteins in cultured cells</article-title>. <source/>J Circadian Rhythms. (<year>2011</year>) <volume>9</volume>:<fpage>12</fpage>. <pub-id pub-id-type="doi">10.1186/1740-3391-9-12</pub-id><pub-id pub-id-type="pmid">22208286</pub-id></mixed-citation>
</ref>
<ref id="B85">
<label>85.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fliers</surname><given-names>E</given-names></name></person-group>
<article-title>The human hypothalamus: basic and clinical aspects</article-title>. <source/>J Neuroendocrinol. (<year>2004</year>) <volume>16</volume>:<fpage>1009</fpage>–<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2826.2005.01255.x</pub-id></mixed-citation>
</ref>
<ref id="B86">
<label>86.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Myers</surname><given-names>SE</given-names></name><name><surname>Davis</surname><given-names>A</given-names></name><name><surname>Whitman</surname><given-names>BY</given-names></name><name><surname>Santiago</surname><given-names>JV</given-names></name><name><surname>Landt</surname><given-names>M</given-names></name></person-group>. <article-title>Leptin concentrations in Prader-Willi syndrome before and after growth hormone replacement</article-title>. <source/>Clin Endocrinol. (<year>2000</year>) <volume>52</volume>:<fpage>101</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2265.2000.00868.x</pub-id><pub-id pub-id-type="pmid">10651760</pub-id></mixed-citation>
</ref>
<ref id="B87">
<label>87.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mercer</surname><given-names>RE</given-names></name><name><surname>Michaelson</surname><given-names>SD</given-names></name><name><surname>Chee</surname><given-names>MJS</given-names></name><name><surname>Atallah</surname><given-names>TA</given-names></name><name><surname>Wevrick</surname><given-names>R</given-names></name><name><surname>Colmers</surname><given-names>WF</given-names></name></person-group>. <article-title><italic>MAGEL2</italic> is required for leptin-mediated depolarization of POMC neurons in the hypothalamic arcuate nucleus in mice</article-title>. <source/>PLoS Genet. (<year>2013</year>) <volume>9</volume>:<fpage>e1003207</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1003207</pub-id><pub-id pub-id-type="pmid">23341784</pub-id></mixed-citation>
</ref>
<ref id="B88">
<label>88.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varela</surname><given-names>L</given-names></name><name><surname>Horvath</surname><given-names>TL</given-names></name></person-group>. <article-title>Leptin and insulin pathways in POMC and AgRP neurons that modulate energy balance and glucose homeostasis</article-title>. <source/>EMBO Rep. (<year>2012</year>) <volume>13</volume>:<fpage>1079</fpage>–<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1038/embor.2012.174</pub-id><pub-id pub-id-type="pmid">23146889</pub-id></mixed-citation>
</ref>
<ref id="B89">
<label>89.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mercer</surname><given-names>RE</given-names></name><name><surname>Wevrick</surname><given-names>R</given-names></name></person-group>. <article-title>Loss of <italic>MAGEL2</italic>, a candidate gene for features of Prader-Willi syndrome, impairs reproductive function in mice</article-title>. <source/>PLoS ONE. (<year>2009</year>) <volume>4</volume>:<fpage>e4291</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0004291</pub-id><pub-id pub-id-type="pmid">19172181</pub-id></mixed-citation>
</ref>
<ref id="B90">
<label>90.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoon</surname><given-names>H</given-names></name><name><surname>Enquist</surname><given-names>LW</given-names></name><name><surname>Dulac</surname><given-names>C</given-names></name></person-group>. <article-title>Olfactory inputs to hypothalamic neurons controlling reproduction and fertility</article-title>. <source/>Cell. (<year>2005</year>) <volume>123</volume>:<fpage>669</fpage>–<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2005.08.039</pub-id><pub-id pub-id-type="pmid">16290037</pub-id></mixed-citation>
</ref>
<ref id="B91">
<label>91.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fountain</surname><given-names>MD</given-names></name><name><surname>Schaaf</surname><given-names>CP</given-names></name></person-group>. <article-title>Prader-Willi syndrome and Schaaf-Yang syndrome: neurodevelopmental diseases intersecting at the <italic>MAGEL2</italic> gene</article-title>. <source/>Diseases. (<year>2016</year>) <volume>4</volume>:<fpage>E2</fpage>. <pub-id pub-id-type="doi">10.3390/diseases4010002</pub-id><pub-id pub-id-type="pmid">28933382</pub-id></mixed-citation>
</ref>
<ref id="B92">
<label>92.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCarthy</surname><given-names>J</given-names></name><name><surname>Lupo</surname><given-names>PJ</given-names></name><name><surname>Kovar</surname><given-names>E</given-names></name><name><surname>Rech</surname><given-names>M</given-names></name><name><surname>Bostwick</surname><given-names>B</given-names></name><name><surname>Scott</surname><given-names>D</given-names></name><etal></etal></person-group>. <article-title>Schaaf-Yang syndrome overview: report of 78 individuals</article-title>. <source/>Am J Med Genet Part A. (<year>2018</year>) <volume>176</volume>:<fpage>2564</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.40650</pub-id><pub-id pub-id-type="pmid">30302899</pub-id></mixed-citation>
</ref>
<ref id="B93">
<label>93.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>NLG</given-names></name><name><surname>Wevrick</surname><given-names>R</given-names></name><name><surname>Mellon</surname><given-names>PL</given-names></name></person-group>. <article-title>Necdin, a Prader-Willi syndrome candidate gene, regulates gonadotropin-releasing hormone neurons during development</article-title>. <source/>Hum Mol Genet. (<year>2008</year>) <volume>18</volume>:<fpage>248</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddn344</pub-id><pub-id pub-id-type="pmid">18930956</pub-id></mixed-citation>
</ref>
<ref id="B94">
<label>94.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jay</surname><given-names>P</given-names></name><name><surname>Rougeulle</surname><given-names>C</given-names></name><name><surname>Massacrier</surname><given-names>A</given-names></name><name><surname>Moncla</surname><given-names>A</given-names></name><name><surname>Mattel</surname><given-names>M</given-names></name><name><surname>Malzac</surname><given-names>P</given-names></name><etal></etal></person-group>. <article-title>The human necdin gene, <italic>NDN</italic>, is maternally imprinted and located in the Prader-Willi syndrome chromosomal region</article-title>. <source/>Nat Genet. (<year>1997</year>) <volume>17</volume>:<fpage>357</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1038/ng1197-357</pub-id><pub-id pub-id-type="pmid">9354807</pub-id></mixed-citation>
</ref>
<ref id="B95">
<label>95.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Walker</surname><given-names>CL</given-names></name><name><surname>Karten</surname><given-names>B</given-names></name><name><surname>Kuny</surname><given-names>SL</given-names></name><name><surname>Tennese</surname><given-names>AA</given-names></name><name><surname>O'Neill</surname><given-names>MA</given-names></name><etal></etal></person-group>. <article-title>Essential role for the Prader–Willi syndrome protein necdin in axonal outgrowth</article-title>. <source/>Hum Mol Genet. (<year>2005</year>) <volume>14</volume>:<fpage>627</fpage>–<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddi059</pub-id><pub-id pub-id-type="pmid">15649943</pub-id></mixed-citation>
</ref>
<ref id="B96">
<label>96.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watrin</surname><given-names>F</given-names></name><name><surname>Roëckel</surname><given-names>N</given-names></name><name><surname>Lacroix</surname><given-names>L</given-names></name><name><surname>Mignon</surname><given-names>C</given-names></name><name><surname>Mattei</surname><given-names>MG</given-names></name><name><surname>Disteche</surname><given-names>C</given-names></name><etal></etal></person-group>. <article-title>The mouse Necdin gene is expressed from the paternal allele only and lies in the 7C region of the mouse chromosome 7, a region of conserved synteny to the human Prader-Willi syndrome region</article-title>. <source/>Eur J Hum Genet. (<year>1997</year>) <volume>5</volume>:<fpage>324</fpage>–<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1159/000484784</pub-id><pub-id pub-id-type="pmid">9412790</pub-id></mixed-citation>
</ref>
<ref id="B97">
<label>97.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>J</given-names></name><name><surname>Silverstein</surname><given-names>J</given-names></name><name><surname>Shuster</surname><given-names>J</given-names></name><name><surname>Driscoll</surname><given-names>DJ</given-names></name><name><surname>Wagner</surname><given-names>M</given-names></name></person-group>. <article-title>Short-term effects of growth hormone on sleep abnormalities in Prader-Willi syndrome</article-title>. <source/>J Clin Endocrinol Metab. (<year>2006</year>) <volume>91</volume>:<fpage>413</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2005-1279</pub-id><pub-id pub-id-type="pmid">16317059</pub-id></mixed-citation>
</ref>
<ref id="B98">
<label>98.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muscatelli</surname><given-names>F</given-names></name></person-group>
<article-title>Disruption of the mouse necdin gene results in hypothalamic and behavioral alteratio ns reminiscent of the human Prader-Willi syndrome</article-title>. <source/>Hum Mol Genet. (<year>2000</year>) <volume>9</volume>:<fpage>3101</fpage>–<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/9.20.3101</pub-id><pub-id pub-id-type="pmid">11115855</pub-id></mixed-citation>
</ref>
<ref id="B99">
<label>99.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zanella</surname><given-names>S</given-names></name><name><surname>Watrin</surname><given-names>F</given-names></name><name><surname>Mebarek</surname><given-names>S</given-names></name><name><surname>Marly</surname><given-names>F</given-names></name><name><surname>Roussel</surname><given-names>M</given-names></name><name><surname>Gire</surname><given-names>C</given-names></name><etal></etal></person-group>. <article-title>Necdin plays a role in the serotonergic modulation of the mouse respiratory network: implication for Prader-Willi syndrome</article-title>. <source/>J Neurosci. (<year>2008</year>) <volume>28</volume>:<fpage>1745</fpage>–<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4334-07.2008</pub-id><pub-id pub-id-type="pmid">18272695</pub-id></mixed-citation>
</ref>
<ref id="B100">
<label>100.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanber</surname><given-names>D</given-names></name><name><surname>Giltay</surname><given-names>J</given-names></name><name><surname>Wieczorek</surname><given-names>D</given-names></name><name><surname>Zogel</surname><given-names>C</given-names></name><name><surname>Hochstenbach</surname><given-names>R</given-names></name><name><surname>Caliebe</surname><given-names>A</given-names></name><etal></etal></person-group>
<article-title>A paternal deletion of MKRN3, MAGEL2 and NDN does not result in Prader-Willi syndrome</article-title>. <source/>Eur J Hum Genet. (<year>2009</year>) <volume>17</volume>:<fpage>582</fpage>–<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1038/ejhg.2008.232</pub-id><pub-id pub-id-type="pmid">19066619</pub-id></mixed-citation>
</ref>
<ref id="B101">
<label>101.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>S</given-names></name></person-group>. <article-title>Expression and imprinting of <italic>MAGEL2</italic> suggest a role in Prader-Willi syndrome and the homologous murine imprinting phenotype</article-title>. <source/>Hum Mol Genet. (<year>2000</year>) <volume>9</volume>:<fpage>1813</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/9.12.1813</pub-id><pub-id pub-id-type="pmid">10915770</pub-id></mixed-citation>
</ref>
<ref id="B102">
<label>102.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pagliardini</surname><given-names>S</given-names></name><name><surname>Ren</surname><given-names>J</given-names></name><name><surname>Wevrick</surname><given-names>R</given-names></name><name><surname>Greer</surname><given-names>JJ</given-names></name></person-group>. <article-title>Developmental abnormalities of neuronal structure and function in prenatal mice lacking the Prader-Willi syndrome gene necdin</article-title>. <source/>Am J Pathol. (<year>2005</year>) <volume>167</volume>:<fpage>175</fpage>–<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1016/S0002-9440(10)62964-1</pub-id><pub-id pub-id-type="pmid">15972963</pub-id></mixed-citation>
</ref>
<ref id="B103">
<label>103.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhanoa</surname><given-names>JK</given-names></name><name><surname>Sethi</surname><given-names>RS</given-names></name><name><surname>Verma</surname><given-names>R</given-names></name><name><surname>Arora</surname><given-names>JS</given-names></name><name><surname>Mukhopadhyay</surname><given-names>CS</given-names></name></person-group>. <article-title>Long non-coding RNA: its evolutionary relics and biological implications in mammals: a review</article-title>. <source/>J Anim Sci Technol. (<year>2018</year>) <volume>60</volume>:<fpage>25</fpage>. <pub-id pub-id-type="doi">10.1186/s40781-018-0183-7</pub-id><pub-id pub-id-type="pmid">30386629</pub-id></mixed-citation>
</ref>
<ref id="B104">
<label>104.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandes</surname><given-names>J</given-names></name><name><surname>Acuña</surname><given-names>S</given-names></name><name><surname>Aoki</surname><given-names>J</given-names></name><name><surname>Floeter-Winter</surname><given-names>L</given-names></name><name><surname>Muxel</surname><given-names>S</given-names></name></person-group>. <article-title>Long non-coding RNA<italic>s</italic> in the regulation of gene expression: physiology and disease</article-title>. <source/>Non-Coding RNA. (<year>2019</year>) <volume>5</volume>:<fpage>17</fpage>. <pub-id pub-id-type="doi">10.3390/ncrna5010017</pub-id><pub-id pub-id-type="pmid">30781588</pub-id></mixed-citation>
</ref>
<ref id="B105">
<label>105.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mercer</surname><given-names>TR</given-names></name><name><surname>Dinger</surname><given-names>ME</given-names></name><name><surname>Mattick</surname><given-names>JS</given-names></name></person-group>. <article-title>Long non-coding RNAs: insights into functions</article-title>. <source/>Nat Rev Genet. (<year>2009</year>) <volume>10</volume>:<fpage>155</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1038/nrg2521</pub-id><pub-id pub-id-type="pmid">19188922</pub-id></mixed-citation>
</ref>
<ref id="B106">
<label>106.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buiting</surname><given-names>K</given-names></name><name><surname>Nazlican</surname><given-names>H</given-names></name><name><surname>Galetzka</surname><given-names>D</given-names></name><name><surname>Wawrzik</surname><given-names>M</given-names></name><name><surname>Groβ</surname><given-names>S</given-names></name><name><surname>Horsthemke</surname><given-names>B</given-names></name></person-group>. <article-title>C15orf2 and a novel noncoding transcript from the Prader–Willi/Angelman syndrome region show monoallelic expression in fetal brain</article-title>. <source/>Genomics. (<year>2007</year>) <volume>89</volume>:<fpage>588</fpage>–<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1016/j.ygeno.2006.12.008</pub-id><pub-id pub-id-type="pmid">17337158</pub-id></mixed-citation>
</ref>
<ref id="B107">
<label>107.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wawrzik</surname><given-names>M</given-names></name><name><surname>Spiess</surname><given-names>A-N</given-names></name><name><surname>Herrmann</surname><given-names>R</given-names></name><name><surname>Buiting</surname><given-names>K</given-names></name><name><surname>Horsthemke</surname><given-names>B</given-names></name></person-group>. <article-title>Expression of SNURF–SNRPN upstream transcripts and epigenetic regulatory genes during human spermatogenesis</article-title>. <source/>Eur J Hum Genet. (<year>2009</year>) <volume>17</volume>:<fpage>1463</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1038/ejhg.2009.83</pub-id><pub-id pub-id-type="pmid">19471314</pub-id></mixed-citation>
</ref>
<ref id="B108">
<label>108.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Ju</surname><given-names>H</given-names></name><name><surname>Yu</surname><given-names>S</given-names></name><name><surname>Zhao</surname><given-names>T</given-names></name><name><surname>Jing</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><etal></etal></person-group>. <article-title>Prader–Willi region non-protein coding RNA 1 suppressed gastric cancer growth as a competing endogenous RNA of MiR-425-5p</article-title>. <source/>Clin Sci. (<year>2018</year>) <volume>132</volume>:<fpage>1003</fpage>–<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1042/CS20171588</pub-id><pub-id pub-id-type="pmid">29535266</pub-id></mixed-citation>
</ref>
<ref id="B109">
<label>109.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kung</surname><given-names>JTY</given-names></name><name><surname>Colognori</surname><given-names>D</given-names></name><name><surname>Lee</surname><given-names>JT</given-names></name></person-group>. <article-title>Long noncoding RNAs: past, present, and future</article-title>. <source/>Genetics. (<year>2013</year>) <volume>193</volume>:<fpage>651</fpage>–<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1534/genetics.112.146704</pub-id><pub-id pub-id-type="pmid">23463798</pub-id></mixed-citation>
</ref>
<ref id="B110">
<label>110.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Wevrick</surname><given-names>R</given-names></name></person-group>. <article-title>Identification of novel imprinted transcripts in the Prader-Willi syndrome and angelman syndrome deletion region: further evidence for regional imprinting control</article-title>. <source/>Am J Hum Genet. (<year>2000</year>) <volume>66</volume>:<fpage>848</fpage>–<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1086/302817</pub-id><pub-id pub-id-type="pmid">10712201</pub-id></mixed-citation>
</ref>
<ref id="B111">
<label>111.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Färber</surname><given-names>C</given-names></name><name><surname>Groß</surname><given-names>S</given-names></name><name><surname>Neesen</surname><given-names>J</given-names></name><name><surname>Buiting</surname><given-names>K</given-names></name><name><surname>Horsthemke</surname><given-names>B</given-names></name></person-group>. <article-title>Identification of a testis-specific gene (C15orf2) in the Prader–Willi syndrome region on chromosome 15</article-title>. <source/>Genomics. (<year>2000</year>) <volume>65</volume>:<fpage>174</fpage>–<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1006/geno.2000.6158</pub-id><pub-id pub-id-type="pmid">10783265</pub-id></mixed-citation>
</ref>
<ref id="B112">
<label>112.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neumann</surname><given-names>LC</given-names></name><name><surname>Markaki</surname><given-names>Y</given-names></name><name><surname>Mladenov</surname><given-names>E</given-names></name><name><surname>Hoffmann</surname><given-names>D</given-names></name><name><surname>Buiting</surname><given-names>K</given-names></name><name><surname>Horsthemke</surname><given-names>B</given-names></name></person-group>. <article-title>The imprinted <italic>NPAP1</italic>/C15orf2 gene in the Prader–Willi syndrome region encodes a nuclear pore complex associated protein</article-title>. <source/>Hum Mol Genet. (<year>2012</year>) <volume>21</volume>:<fpage>4038</fpage>–<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/dds228</pub-id><pub-id pub-id-type="pmid">22694955</pub-id></mixed-citation>
</ref>
<ref id="B113">
<label>113.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gray</surname><given-names>TA</given-names></name><name><surname>Saitoh</surname><given-names>S</given-names></name><name><surname>Nicholls</surname><given-names>RD</given-names></name></person-group>. <article-title>An imprinted, mammalian bicistronic transcript encodes two independent proteins</article-title>. <source/>Proc Natl Acad Sci USA. (<year>1999</year>) <volume>96</volume>:<fpage>5616</fpage>–<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.96.10.5616</pub-id><pub-id pub-id-type="pmid">10318933</pub-id></mixed-citation>
</ref>
<ref id="B114">
<label>114.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Özçelik</surname><given-names>T</given-names></name><name><surname>Leff</surname><given-names>S</given-names></name><name><surname>Robinson</surname><given-names>W</given-names></name><name><surname>Donlon</surname><given-names>T</given-names></name><name><surname>Lalande</surname><given-names>M</given-names></name><name><surname>Sanjines</surname><given-names>E</given-names></name><etal></etal></person-group>. <article-title>Small nuclear ribonucleoprotein polypeptide N (SNRPN), an expressed gene in the Prader–Willi syndrome critical region</article-title>. <source/>Nat Genet. (<year>1992</year>) <volume>2</volume>:<fpage>265</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1038/ng1292-265</pub-id><pub-id pub-id-type="pmid">1303277</pub-id></mixed-citation>
</ref>
<ref id="B115">
<label>115.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez-Jato</surname><given-names>S</given-names></name><name><surname>Nicholls</surname><given-names>RD</given-names></name><name><surname>Driscoll</surname><given-names>DJ</given-names></name><name><surname>Yang</surname><given-names>TP</given-names></name></person-group>. <article-title>Characterization of cis- and trans-acting elements in the imprinted human <italic>SNURF-SNRPN</italic> locus</article-title>. <source/>Nucleic Acids Res. (<year>2005</year>) <volume>33</volume>:<fpage>4740</fpage>–<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gki786</pub-id><pub-id pub-id-type="pmid">16116039</pub-id></mixed-citation>
</ref>
<ref id="B116">
<label>116.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>Y</given-names></name><name><surname>AlHumaidi</surname><given-names>SS</given-names></name><name><surname>Faqeih</surname><given-names>EA</given-names></name><name><surname>Pitel</surname><given-names>BA</given-names></name><name><surname>Lundquist</surname><given-names>P</given-names></name><name><surname>Aypar</surname><given-names>U</given-names></name></person-group>. <article-title>A novel deletion of SNURF/SNRPN Exon 1 in a patient with Prader-Willi-like phenotype</article-title>. <source/>Eur J Med Genet. (<year>2017</year>) <volume>60</volume>:<fpage>416</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmg.2017.05.003</pub-id><pub-id pub-id-type="pmid">28554868</pub-id></mixed-citation>
</ref>
<ref id="B117">
<label>117.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geuns</surname><given-names>E</given-names></name></person-group>. <article-title>Methylation imprints of the imprint control region of the SNRPN-gene in human gametes and preimplantation embryos</article-title>. <source/>Hum Mol Genet. (<year>2003</year>) <volume>12</volume>:<fpage>2873</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddg315</pub-id><pub-id pub-id-type="pmid">14500540</pub-id></mixed-citation>
</ref>
<ref id="B118">
<label>118.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cavaillé</surname><given-names>J</given-names></name><name><surname>Buiting</surname><given-names>K</given-names></name><name><surname>Kiefmann</surname><given-names>M</given-names></name><name><surname>Lalande</surname><given-names>M</given-names></name><name><surname>Brannan</surname><given-names>CI</given-names></name><name><surname>Horsthemke</surname><given-names>B</given-names></name><etal></etal></person-group>. <article-title>Identification of brain-specific and imprinted small nucleolar RNA genes exhibiting an unusual genomic organization</article-title>. <source/>Proc Natl Acad Sci USA. (<year>2000</year>) <volume>97</volume>:<fpage>14311</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.250426397</pub-id><pub-id pub-id-type="pmid">11106375</pub-id></mixed-citation>
</ref>
<ref id="B119">
<label>119.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castle</surname><given-names>JC</given-names></name><name><surname>Armour</surname><given-names>CD</given-names></name><name><surname>Löwer</surname><given-names>M</given-names></name><name><surname>Haynor</surname><given-names>D</given-names></name><name><surname>Biery</surname><given-names>M</given-names></name><name><surname>Bouzek</surname><given-names>H</given-names></name><etal></etal></person-group>. <article-title>Digital genome-wide NcRNA expression, including SnoRNAs, across 11 human tissues using polyA-neutral amplification</article-title>. <source/>PLoS ONE. (<year>2010</year>) <volume>5</volume>:<fpage>e11779</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0011779</pub-id><pub-id pub-id-type="pmid">20668672</pub-id></mixed-citation>
</ref>
<ref id="B120">
<label>120.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chamberlain</surname><given-names>SJ</given-names></name><name><surname>Chen</surname><given-names>PF</given-names></name><name><surname>Ng</surname><given-names>KY</given-names></name><name><surname>Bourgois-Rocha</surname><given-names>F</given-names></name><name><surname>Lemtiri-Chlieh</surname><given-names>F</given-names></name><name><surname>Levine</surname><given-names>ES</given-names></name><etal></etal></person-group>. <article-title>Induced pluripotent stem cell models of the genomic imprinting disorders angelman and Prader-Willi Syndromes</article-title>. <source/>Proc Natl Acad Sci USA. (<year>2010</year>) <volume>107</volume>:<fpage>17668</fpage>–<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1004487107</pub-id><pub-id pub-id-type="pmid">20876107</pub-id></mixed-citation>
</ref>
<ref id="B121">
<label>121.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martins-Taylor</surname><given-names>K</given-names></name><name><surname>Hsiao</surname><given-names>JS</given-names></name><name><surname>Chen</surname><given-names>P-F</given-names></name><name><surname>Glatt-Deeley</surname><given-names>H</given-names></name><name><surname>De Smith</surname><given-names>AJ</given-names></name><name><surname>Blakemore</surname><given-names>AIF</given-names></name><etal></etal></person-group>. <article-title>Imprinted expression of <italic>UBE3A</italic> in non-neuronal cells from a Prader–Willi syndrome patient with an atypical deletion</article-title>. <source/>Hum Mol Genet. (<year>2014</year>) <volume>23</volume>:<fpage>2364</fpage>–<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddt628</pub-id><pub-id pub-id-type="pmid">24363065</pub-id></mixed-citation>
</ref>
<ref id="B122">
<label>122.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vitali</surname><given-names>P</given-names></name><name><surname>Royo</surname><given-names>H</given-names></name><name><surname>Marty</surname><given-names>V</given-names></name><name><surname>Bortolin-Cavaille</surname><given-names>M-L</given-names></name><name><surname>Cavaille</surname><given-names>J</given-names></name></person-group>. <article-title>Long nuclear-retained non-coding RNAs and allele-specific higher-order chromatin organization at imprinted snoRNA gene arrays</article-title>. <source/>J Cell Sci. (<year>2010</year>) <volume>123</volume>:<fpage>70</fpage>–<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.054957</pub-id><pub-id pub-id-type="pmid">20016068</pub-id></mixed-citation>
</ref>
<ref id="B123">
<label>123.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cavaillé</surname><given-names>J</given-names></name></person-group>
<article-title>Box C/D small nucleolar RNA genes and the Prader-Willi syndrome: a complex interplay: box C/D SnoRNA genes and the Prader-Willi syndrome</article-title>. <source/>Wiley Interdiscipl. Rev. RNA. (<year>2017</year>) <volume>8</volume>:<fpage>e1417</fpage>
<pub-id pub-id-type="doi">10.1002/wrna.1417</pub-id></mixed-citation>
</ref>
<ref id="B124">
<label>124.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>YJ</given-names></name><name><surname>Yang</surname><given-names>JH</given-names></name><name><surname>Shi</surname><given-names>QS</given-names></name><name><surname>Zheng</surname><given-names>LL</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name><etal></etal></person-group>. <article-title>Rapid birth-and-death evolution of imprinted snoRNAs in the Prader-Willi syndrome locus: implications for neural development in <italic>Euarchontoglires</italic></article-title>. <source/>PLoS ONE. (<year>2014</year>) <volume>9</volume>:<fpage>e100329</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0100329</pub-id><pub-id pub-id-type="pmid">24945811</pub-id></mixed-citation>
</ref>
<ref id="B125">
<label>125.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bieth</surname><given-names>E</given-names></name><name><surname>Eddiry</surname><given-names>E</given-names></name><name><surname>Gaston</surname><given-names>V</given-names></name><name><surname>Lorenzini</surname><given-names>F</given-names></name><name><surname>Buffet</surname><given-names>A</given-names></name><name><surname>Conte</surname><given-names>AF</given-names></name><etal></etal></person-group>. <article-title>Highly restricted deletion of the <italic>SNORD116</italic> region is implicated in Prader–Willi syndrome</article-title>. <source/>Eur J Hum Genet. (<year>2015</year>) <volume>23</volume>:<fpage>252</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1038/ejhg.2014.103</pub-id><pub-id pub-id-type="pmid">24916642</pub-id></mixed-citation>
</ref>
<ref id="B126">
<label>126.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duker</surname><given-names>AL</given-names></name><name><surname>Ballif</surname><given-names>BC</given-names></name><name><surname>Bawle</surname><given-names>EV</given-names></name><name><surname>Person</surname><given-names>RE</given-names></name><name><surname>Mahadevan</surname><given-names>S</given-names></name><name><surname>Alliman</surname><given-names>S</given-names></name><etal></etal></person-group>. <article-title>Paternally inherited microdeletion at 15q11.2 confirms a significant role for the <italic>SNORD116</italic> C/D box SnoRNA cluster in Prader–Willi syndrome</article-title>. <source/>Eur J Hum Genet. (<year>2010</year>) <volume>18</volume>:<fpage>1196</fpage>–<lpage>201</lpage>. <pub-id pub-id-type="doi">10.1038/ejhg.2010.102</pub-id><pub-id pub-id-type="pmid">20588305</pub-id></mixed-citation>
</ref>
<ref id="B127">
<label>127.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sahoo</surname><given-names>T</given-names></name><name><surname>del Gaudio</surname><given-names>D</given-names></name><name><surname>German</surname><given-names>JR</given-names></name><name><surname>Shinawi</surname><given-names>M</given-names></name><name><surname>Peters</surname><given-names>SU</given-names></name><name><surname>Person</surname><given-names>RE</given-names></name><etal></etal></person-group>. <article-title>Prader-Willi phenotype caused by paternal deficiency for the HBII-85 C/D box small nucleolar RNA cluster</article-title>. <source/>Nat Genet. (<year>2008</year>) <volume>40</volume>:<fpage>719</fpage>–<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1038/ng.158</pub-id><pub-id pub-id-type="pmid">18500341</pub-id></mixed-citation>
</ref>
<ref id="B128">
<label>128.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Smith</surname><given-names>AJ</given-names></name><name><surname>Purmann</surname><given-names>C</given-names></name><name><surname>Walters</surname><given-names>RG</given-names></name><name><surname>Ellis</surname><given-names>RJ</given-names></name><name><surname>Holder</surname><given-names>SE</given-names></name><name><surname>Van Haelst</surname><given-names>MM</given-names></name><etal></etal></person-group>. <article-title>A deletion of the HBII-85 class of small nucleolar RNAs (snoRNAs) is associated with hyperphagia, obesity and hypogonadism</article-title>. <source/>Hum Mol Genet. (<year>2009</year>) <volume>18</volume>:<fpage>3257</fpage>–<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddp263</pub-id><pub-id pub-id-type="pmid">19498035</pub-id></mixed-citation>
</ref>
<ref id="B129">
<label>129.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>HH</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Solomon</surname><given-names>NM</given-names></name><name><surname>Camper</surname><given-names>SA</given-names></name><name><surname>Cohen</surname><given-names>P</given-names></name><etal></etal></person-group>. <article-title>SnoRNA <italic>SNORD116</italic> (Pwcr1/MBII-85) deletion causes growth deficiency and hyperphagia in mice</article-title>. <source/>PLoS ONE. (<year>2008</year>) <volume>3</volume>:<fpage>e1709</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0001709</pub-id><pub-id pub-id-type="pmid">18320030</pub-id></mixed-citation>
</ref>
<ref id="B130">
<label>130.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qi</surname><given-names>Y</given-names></name><name><surname>Purtell</surname><given-names>L</given-names></name><name><surname>Fu</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>NJ</given-names></name><name><surname>Aepler</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><etal></etal></person-group>. <article-title><italic>SNORD116</italic> is critical in the regulation of food intake and body weight</article-title>. <source/>Sci Rep. (<year>2016</year>) <volume>6</volume>:<fpage>18614</fpage>. <pub-id pub-id-type="doi">10.1038/srep18614</pub-id><pub-id pub-id-type="pmid">26726071</pub-id></mixed-citation>
</ref>
<ref id="B131">
<label>131.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rozhdestvensky</surname><given-names>TS</given-names></name><name><surname>Robeck</surname><given-names>T</given-names></name><name><surname>Galiveti</surname><given-names>CR</given-names></name><name><surname>Raabe</surname><given-names>CA</given-names></name><name><surname>Seeger</surname><given-names>B</given-names></name><name><surname>Wolters</surname><given-names>A</given-names></name><etal></etal></person-group>. <article-title>Maternal transcription of non-protein coding RNAs from the PWS-critical region rescues growth retardation in mice</article-title>. <source/>Sci Rep. (<year>2016</year>) <volume>6</volume>:<fpage>20398</fpage>. <pub-id pub-id-type="doi">10.1038/srep20398</pub-id><pub-id pub-id-type="pmid">26848093</pub-id></mixed-citation>
</ref>
<ref id="B132">
<label>132.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skryabin</surname><given-names>BV</given-names></name><name><surname>Gubar</surname><given-names>LV</given-names></name><name><surname>Seeger</surname><given-names>B</given-names></name><name><surname>Pfeiffer</surname><given-names>J</given-names></name><name><surname>Handel</surname><given-names>S</given-names></name><name><surname>Robeck</surname><given-names>T</given-names></name><etal></etal></person-group>. <article-title>Deletion of the MBII-85 snoRNA gene cluster in mice results in postnatal growth retardation</article-title>. <source/>PLoS Genet. (<year>2007</year>) <volume>3</volume>:<fpage>e235</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.0030235</pub-id><pub-id pub-id-type="pmid">18166085</pub-id></mixed-citation>
</ref>
<ref id="B133">
<label>133.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burnett</surname><given-names>LC</given-names></name><name><surname>LeDuc</surname><given-names>CA</given-names></name><name><surname>Sulsona</surname><given-names>CR</given-names></name><name><surname>Paull</surname><given-names>D</given-names></name><name><surname>Rausch</surname><given-names>R</given-names></name><name><surname>Eddiry</surname><given-names>S</given-names></name><etal></etal></person-group>. <article-title>Deficiency in prohormone convertase PC1 impairs prohormone processing in Prader-Willi syndrome</article-title>. <source/>J Clin Invest. (<year>2017</year>) <volume>127</volume>:<fpage>293</fpage>–<lpage>305</lpage>. <pub-id pub-id-type="doi">10.1172/JCI88648</pub-id><pub-id pub-id-type="pmid">27941249</pub-id></mixed-citation>
</ref>
<ref id="B134">
<label>134.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coulson</surname><given-names>RL</given-names></name><name><surname>Yasui</surname><given-names>DH</given-names></name><name><surname>Dunaway</surname><given-names>KW</given-names></name><name><surname>Laufer</surname><given-names>BI</given-names></name><name><surname>Vogel Ciernia</surname><given-names>A</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><etal></etal></person-group>. <article-title>Snord116-dependent diurnal rhythm of DNA methylation in mouse cortex</article-title>. <source/>Nat Commun. (<year>2018</year>) <volume>9</volume>:<fpage>1616</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-018-03676-0</pub-id><pub-id pub-id-type="pmid">29691382</pub-id></mixed-citation>
</ref>
<ref id="B135">
<label>135.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bürger</surname><given-names>J</given-names></name><name><surname>Horn</surname><given-names>D</given-names></name><name><surname>Tönnies</surname><given-names>H</given-names></name><name><surname>Neitzel</surname><given-names>H</given-names></name><name><surname>Reis</surname><given-names>A</given-names></name></person-group>
<article-title>Familial interstitial 570 Kbp deletion of the <italic>UBE3A</italic> gene region causing angelman syndrome but not Prader-Willi syndrome: familial <italic>UBE3A</italic> gene deletion</article-title>. <source/>Am J Med Genet. (<year>2002</year>) <volume>111</volume>:<fpage>233</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.10498</pub-id><pub-id pub-id-type="pmid">12210318</pub-id></mixed-citation>
</ref>
<ref id="B136">
<label>136.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Runte</surname><given-names>M</given-names></name><name><surname>Varon</surname><given-names>R</given-names></name><name><surname>Horn</surname><given-names>D</given-names></name><name><surname>Horsthemke</surname><given-names>B</given-names></name><name><surname>Buiting</surname><given-names>K</given-names></name></person-group>. <article-title>Exclusion of the C/D box snoRNA gene cluster HBII-52 from a major role in Prader?</article-title> Willi syndrome. <source/>Hum Genet. (<year>2005</year>) <volume>116</volume>:<fpage>228</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1007/s00439-004-1219-2</pub-id><pub-id pub-id-type="pmid">15565282</pub-id></mixed-citation>
</ref>
<ref id="B137">
<label>137.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stelzer</surname><given-names>Y</given-names></name><name><surname>Sagi</surname><given-names>I</given-names></name><name><surname>Yanuka</surname><given-names>O</given-names></name><name><surname>Eiges</surname><given-names>R</given-names></name><name><surname>Benvenisty</surname><given-names>N</given-names></name></person-group>. <article-title>The noncoding RNA <italic>IPW</italic> regulates the imprinted DLK1-DIO3 locus in an induced pluripotent stem cell model of Prader-Willi syndrome</article-title>. <source/>Nat Genet. (<year>2014</year>) <volume>46</volume>:<fpage>551</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1038/ng.2968</pub-id><pub-id pub-id-type="pmid">24816254</pub-id></mixed-citation>
</ref>
<ref id="B138">
<label>138.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wevrick</surname><given-names>R</given-names></name><name><surname>Francke</surname><given-names>U</given-names></name></person-group>. <article-title>An imprinted mouse transcript homologous to the human imprinted in Prader-Willi syndrome (<italic>IPW</italic>) gene</article-title>. <source/>Hum Mol Genet. (<year>1997</year>) <volume>6</volume>:<fpage>325</fpage>–<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/6.2.325</pub-id><pub-id pub-id-type="pmid">9063754</pub-id></mixed-citation>
</ref>
<ref id="B139">
<label>139.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>F</given-names></name><name><surname>Prints</surname><given-names>Y</given-names></name><name><surname>Dhar</surname><given-names>MS</given-names></name><name><surname>Johnson</surname><given-names>DK</given-names></name><name><surname>Montero</surname><given-names>CC</given-names></name><name><surname>Nicholls</surname><given-names>RD</given-names></name><etal></etal></person-group>. <article-title>Lack of Pwcr1/MBII-85 SnoRNA is critical for neonatal lethality in Prader–Willi syndrome mouse models</article-title>. <source/>Mammalian Genome. (<year>2005</year>) <volume>16</volume>:<fpage>424</fpage>–<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1007/s00335-005-2460-2</pub-id><pub-id pub-id-type="pmid">16075369</pub-id></mixed-citation>
</ref>
<ref id="B140">
<label>140.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falk</surname><given-names>MJ</given-names></name><name><surname>Curtis</surname><given-names>C</given-names></name><name><surname>Bass</surname><given-names>NE</given-names></name><name><surname>Zinn</surname><given-names>AB</given-names></name><name><surname>Schwartz</surname><given-names>S</given-names></name></person-group>. <article-title>Maternal uniparental disomy chromosome 14: case report and literature review</article-title>. <source/>Pediatric Neurol. (<year>2005</year>) <volume>32</volume>:<fpage>116</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2004.07.007</pub-id><pub-id pub-id-type="pmid">15664772</pub-id></mixed-citation>
</ref>
<ref id="B141">
<label>141.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hordijk</surname><given-names>R</given-names></name><name><surname>Wierenga</surname><given-names>H</given-names></name><name><surname>Scheffer</surname><given-names>H</given-names></name><name><surname>Leegte</surname><given-names>B</given-names></name><name><surname>Hofstra</surname><given-names>R</given-names></name><name><surname>Stolte-Dijkstra</surname><given-names>I</given-names></name></person-group>. <article-title>Maternal uniparental disomy for chromosome 14 in a boy with a normal karyotype</article-title>. <source/>J Med Genet. (<year>1999</year>) <volume>36</volume>:<fpage>782</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.36.10.782</pub-id><pub-id pub-id-type="pmid">10528860</pub-id></mixed-citation>
</ref>
<ref id="B142">
<label>142.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hosoki</surname><given-names>K</given-names></name><name><surname>Kagami</surname><given-names>M</given-names></name><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>Kubota</surname><given-names>M</given-names></name><name><surname>Kurosawa</surname><given-names>K</given-names></name><name><surname>Kato</surname><given-names>M</given-names></name><etal></etal></person-group>. <article-title>Maternal Uniparental Disomy 14 Syndrome Demonstrates Prader-Willi Syndrome-Like Phenotype</article-title>. <source/>J Pediatr. (<year>2009</year>) <volume>155</volume>:<fpage>900</fpage>–<lpage>03.e1</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpeds.2009.06.045</pub-id><pub-id pub-id-type="pmid">19800077</pub-id></mixed-citation>
</ref>
<ref id="B143">
<label>143.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murrell</surname><given-names>A</given-names></name></person-group>. <article-title>Cross-talk between imprinted loci in Prader-Willi syndrome</article-title>. <source/>Nat Genet. (<year>2014</year>) <volume>46</volume>:<fpage>528</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1038/ng.2994</pub-id><pub-id pub-id-type="pmid">24866188</pub-id></mixed-citation>
</ref>
<ref id="B144">
<label>144.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patten</surname><given-names>MM</given-names></name><name><surname>Cowley</surname><given-names>M</given-names></name><name><surname>Oakey</surname><given-names>RJ</given-names></name><name><surname>Feil</surname><given-names>R</given-names></name></person-group>. <article-title>Regulatory links between imprinted genes: evolutionary predictions and consequences</article-title>. <source/>Proc R Soc B Biol Sci. (<year>2016</year>) <volume>283</volume>:<fpage>20152760</fpage>. <pub-id pub-id-type="doi">10.1098/rspb.2015.2760</pub-id><pub-id pub-id-type="pmid">26842569</pub-id></mixed-citation>
</ref>
<ref id="B145">
<label>145.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wold</surname><given-names>EA</given-names></name><name><surname>Wild</surname><given-names>CT</given-names></name><name><surname>Cunningham</surname><given-names>KA</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name></person-group>. <article-title>Targeting the 5-HT2C receptor in biological context and the current state of 5-HT2C receptor ligand development</article-title>. <source/>Curr Top Med Chem. (<year>2019</year>) <volume>19</volume>:<fpage>1381</fpage>–<lpage>98</lpage>. <pub-id pub-id-type="doi">10.2174/1568026619666190709101449</pub-id><pub-id pub-id-type="pmid">31288724</pub-id></mixed-citation>
</ref>
<ref id="B146">
<label>146.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nonogaki</surname><given-names>K</given-names></name><name><surname>Strack</surname><given-names>AM</given-names></name><name><surname>Dallman</surname><given-names>MF</given-names></name><name><surname>Tecott</surname><given-names>LH</given-names></name></person-group>. <article-title>Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene</article-title>. <source/>Nat Med. (<year>1998</year>) <volume>4</volume>:<fpage>1152</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1038/2647</pub-id><pub-id pub-id-type="pmid">9771748</pub-id></mixed-citation>
</ref>
<ref id="B147">
<label>147.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tecott</surname><given-names>LH</given-names></name><name><surname>Sun</surname><given-names>LM</given-names></name><name><surname>Akana</surname><given-names>SF</given-names></name><name><surname>Strack</surname><given-names>AM</given-names></name><name><surname>Lowenstein</surname><given-names>DH</given-names></name><name><surname>Dallman</surname><given-names>MF</given-names></name><etal></etal></person-group>. <article-title>Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors</article-title>. <source/>Nature. (<year>1995</year>) <volume>374</volume>:<fpage>542</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1038/374542a0</pub-id><pub-id pub-id-type="pmid">7700379</pub-id></mixed-citation>
</ref>
<ref id="B148">
<label>148.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biswas</surname><given-names>S</given-names></name><name><surname>Rao</surname><given-names>CM</given-names></name></person-group>. <article-title>Epigenetic tools (the writers, the readers and the erasers) and their implications in cancer therapy</article-title>. <source/>Eur J Pharmacol. (<year>2018</year>) <volume>837</volume>:<fpage>8</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2018.08.021</pub-id><pub-id pub-id-type="pmid">30125562</pub-id></mixed-citation>
</ref>
<ref id="B149">
<label>149.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>SE</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name></person-group>. <article-title>Epigenetic therapy of Prader–Willi syndrome</article-title>. <source/>Transl Res. (<year>2019</year>) <volume>208</volume>:<fpage>105</fpage>–<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1016/j.trsl.2019.02.012</pub-id><pub-id pub-id-type="pmid">30904443</pub-id></mixed-citation>
</ref>
<ref id="B150">
<label>150.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>SE</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name></person-group>. <article-title>Potential of epigenetic therapy for Prader-Willi syndrome</article-title>. <source/>Trends Pharmacol Sci. (<year>2019</year>) <volume>40</volume>:<fpage>605</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.tips.2019.07.002</pub-id><pub-id pub-id-type="pmid">31353046</pub-id></mixed-citation>
</ref>
<ref id="B151">
<label>151.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>Y</given-names></name><name><surname>Lee</surname><given-names>H-M</given-names></name><name><surname>Xiong</surname><given-names>Y</given-names></name><name><surname>Sciaky</surname><given-names>N</given-names></name><name><surname>Hulbert</surname><given-names>SW</given-names></name><name><surname>Cao</surname><given-names>X</given-names></name><etal></etal></person-group>. <article-title>Targeting the histone methyltransferase G9a activates imprinted genes and improves survival of a mouse model of Prader–Willi syndrome</article-title>. <source/>Nat Med. (<year>2017</year>) <volume>23</volume>:<fpage>213</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1038/nm.4257</pub-id><pub-id pub-id-type="pmid">28024084</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>